Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CYP4F8		ENSG00000186526	"Cytochrome P450 family 4 subfamily F member 8"	P98187	19	15615218-15630638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	155	"ductus deferens: 265.6;seminal vesicle: 360.6"	"Group enriched"	"Detected in some"	9	"RT4: 1.6;SK-BR-3: 4.5"	"Group enriched"	"Detected in some"	31	"breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058960	Approved									"HPA058960: AB_2683862"	"unprognostic (1.70e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.97e-6)"		"unprognostic (3.51e-3)"				"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-2)"		"unprognostic (1.15e-2)"			"unprognostic (1.02e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	265.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950741-49958881	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;EFO-21: 7.7;HEL: 2.2;HMC-1: 4.7;REH: 1.2"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced									"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.1	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	178.6	0.0	0.1	3.3	0.1	0.1	0.0	0.6	0.1	0.1	96.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.2	108.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PATE1	PATE	ENSG00000171053	"Prostate and testis expressed 1"	Q8WXA2	11	125746293-125749867	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"ductus deferens: 426.3;epididymis: 222.7;seminal vesicle: 185.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;NB-4: 6.4;RPMI-8226: 1.6;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076587	Approved				"Secreted in male reproductive system"					"HPA076587: AB_2732316"																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.3	0.2	0.0	426.3	0.0	0.2	222.7	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	10.0	0.0	0.0	0.2	185.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.0	0.2	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
SEMG1	"CT103, SEMG"	ENSG00000124233	"Semenogelin I"	P04279	20	45206997-45209772	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"ductus deferens: 2077.7;seminal vesicle: 1931.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;NB-4: 1.7;NTERA-2: 3.3;THP-1: 7.7"	"Cancer enriched"	"Detected in some"	14	"prostate cancer: 20.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	192	"eosinophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"									"HPA042476, HPA064892"	Enhanced				"Secreted in male reproductive system"	1700000	1700000			"HPA042476: AB_10794799, HPA064892: AB_2732724"			"unprognostic (3.71e-1)"								"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"		"unprognostic (3.32e-1)"			"unprognostic (1.11e-2)"	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	2077.7	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	76.5	0.0	0.0	0.2	1931.9	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	19.5	0.1	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PATE4	"FLJ41047, PATE-B"	ENSG00000237353	"Prostate and testis expressed 4"	P0C8F1	11	125833316-125840069	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"ductus deferens: 194.5;seminal vesicle: 232.9"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA045632	Approved				"Secreted in male reproductive system"					"HPA045632: AB_10960489"	"unprognostic (4.90e-1)"									"unprognostic (2.93e-2)"		"unprognostic (1.03e-1)"		"unprognostic (1.91e-1)"				0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.4	0.2	0.2	0.1	0.0	194.5	0.0	0.1	7.3	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.1	232.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	2.1	0.2	1.6	1.5	1.2	0.6	0.6	0.9	0.1	0.5	0.5	0.8	1.4	0.4	0.5	0.4	0.3	0.2	0.0	0.3	0.6	0.9	1.6	0.5	0.0	0.9	0.1	0.1	0.4	0.3	0.3	0.6	1.5	0.8	0.1	0.5	3.1	0.7	0.3	0.2	0.6	0.1	0.9	2.6	0.2	0.7	0.2	0.9	1.6	0.8	0.6	0.6	0.6	0.5	1.8	0.4	0.3	0.5	0.1	0.3	0.9	0.1	1.7	1.3	1.5	2.5	0.8	1.4	0.7	0.8	1.1	0.2	1.3	0.6	0.6	0.3	0.9	0.5	0.6	1.4	0.7	0.4	0.3	1.6	0.9	0.8	1.2	0.6	0.4	1.5	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.0
SEMG2	SGII	ENSG00000124157	"Semenogelin II"	Q02383	20	45221300-45224458	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"ductus deferens: 1137.0;seminal vesicle: 1095.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	25	"prostate cancer: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042767, HPA042835"	Enhanced				"Secreted in male reproductive system"	920000	920000			"HPA042767: AB_10959312, HPA042835: AB_10964060"												"unprognostic (1.39e-1)"		"unprognostic (2.17e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1137.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	46.2	0.0	0.0	0.1	1095.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	8.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104855511-104858574	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1"	"Group enriched"	"Detected in some"	6	"AF22: 27.0;AN3-CA: 25.8;HEK 293: 10.0;RPTEC TERT1: 30.6;SH-SY5Y: 8.5"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavourable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			0.2	0.2	9.0	0.1	8.6	0.0	0.1	4.3	18.9	0.0	0.3			0.0	0.0	27.2	0.0	0.0	0.0	0.0	9.9	6.0	23.7	0.0	0.0	0.1	8.9		0.1	0.0	0.0	0.0	0.0		0.0	0.1		0.0	12.1	0.0	0.5	0.0	0.0	10.0	0.0	0.1	0.1			0.0		0.1	0.0	0.0	0.4	0.4	0.9	0.2	0.3	0.2	0.0	0.0	0.0	27.0	25.8	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	3.2	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.8	0.6	0.0	30.6	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.0										
PATE2	"C11orf38, LVLF3112, PATE-M, UNQ3112"	ENSG00000196844	"Prostate and testis expressed 2"	Q6UY27	11	125776113-125778819	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"ductus deferens: 56.1;epididymis: 112.4;seminal vesicle: 44.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"						"unprognostic (3.28e-1)"				"unprognostic (7.26e-2)"	"unprognostic (2.95e-1)"		"unprognostic (1.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.84e-3)"		"unprognostic (1.55e-2)"		"unprognostic (5.08e-1)"	"unprognostic (2.55e-1)"			0.1	0.1	0.4	0.0	1.0	0.1	0.1	0.7	0.6	0.1	0.2	0.0	56.1	0.0	0.1	112.4	0.0	0.1	0.0	0.2	0.5	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	44.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	4.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.2	1.6	0.6	0.2	1.0	0.0	0.9	0.0	0.2	0.7	0.4	0.0	1.7	0.5	0.2	0.6	0.3	0.4	0.8	0.2	0.6	0.5	0.4	0.1	0.3	0.8	0.7	0.3	0.7	1.1	0.0	0.0	0.7	1.4	0.0	0.1	0.7	0.5	0.0	0.6	1.7	0.1	1.6	0.5	4.4	1.6	1.6	1.2	0.1	1.9	0.7	0.7	0.4	0.5	2.6	1.6	0.3	1.4	2.0	2.7	0.8	0.6	0.9	0.6	0.9	0.5	0.8	1.5	0.7	1.5	0.7	0.6	0.6	0.3	0.6	0.2	0.3	0.2	0.1	0.2	0.5	1.0	0.3	1.6	0.2	0.3	0.2	0.3	0.0	0.4	1.0	0.7	0.6	0.5	0.9	1.1	0.0	0.0	0.0
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor, Kazal type 13 (putative)"	Q1W4C9	5	148268180-148286254	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7"	"Cell line enriched"	"Detected in some"	20	"HeLa: 99.6"	"Group enriched"	"Detected in some"	6	"cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036456	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"			"Plasma membrane"	"Plasma membrane"	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.2	0.0	85.5	0.0	0.4	86.8	0.1	1.0	0.1	0.8	0.0	0.1	2.1	0.0	0.1	0.1	0.0	0.0	1.4	0.4	0.0	1.0	0.1	0.0	4.0	0.0	0.0	0.1	26.7	0.1	0.2	0.0	0.1	0.0	0.0	2.9	2.7	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	99.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ELF5		ENSG00000135374	"E74 like ETS transcription factor 5"	Q9UKW6	11	34478793-34513805	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	11	"breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9"	"Group enriched"	"Detected in some"	8	"RT4: 17.4;T-47d: 33.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062706			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062706: AB_2684841"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.41e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.93e-1)"	"prognostic favourable (3.64e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	48.8	0.0	0.0	0.5	0.0	0.0	72.2	0.6	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	6.5	0.0	2.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.8	0.0	1.4	0.0	0.0	85.1	86.9	0.0	3.5	0.0	1.0	0.0	0.3	0.1	0.1	0.0	0.2	0.0	3.5	1.0	5.8	1.2	0.5	0.5	2.0	1.8	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.4	0.0	0.0	0.0	3.0	0.0	33.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.0	0.3	0.2	0.5	1.8	0.3	0.2	0.3	0.4	0.3	0.5	0.4	0.4	0.9	0.7	1.8	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR149	"IEDA, PGR10, R35"	ENSG00000174948	"G protein-coupled receptor 149"	Q86SP6	3	154337672-154429715	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basal ganglia: 23.5;pons and medulla: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 15.0"	"Low region specificity"	"Detected in all"			HPA018020	Uncertain									"HPA018020: AB_1849334"																		0.2	0.3	0.2	0.2	23.5	0.2	0.2	0.0	0.8	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.9	0.2	0.2	0.2	0.2	0.8	0.0	0.2	0.2	0.2	6.5	0.2	6.5	0.3	0.3	0.4	0.2	8.7	0.2	0.3	0.3	0.2	0.6	0.2	0.5	1.1	2.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.5	0.0	0.8	0.2	1.9	0.8	0.0	6.5	2.1
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 93.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in many"			"CAB000113, HPA001335"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.5	0.5	0.0	21.3	93.1	0.1	0.8	3.3	3.9	0.0	0.0	0.1	2.8	0.0	1.7	0.3	0.0	0.0	0.1	0.5	0.0	3.1	0.0	0.1	0.2	0.6	2.6	6.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.0	0.1	0.3	4.5	0.1	3.1	0.1	0.0	0.0	0.0	6.5	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9
KCP	"CRIM2, FLJ33365, NET67"	ENSG00000135253	"Kielin/chordin-like protein"		7	128862451-128910719	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.4;HMC-1: 7.6;U-87 MG: 3.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (6.12e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.33e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.01e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.64e-3)"	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	30.0	0.9	0.1	1.7	0.4	0.6	2.1	0.3	0.0		11.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	28.3	0.0	0.0	2.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	13.4	0.2	2.0	0.0	1.0	0.0	0.0	0.0	1.8	0.1	0.9	0.0	1.1	0.2	0.0	7.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853230	"Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 94.9;seminal vesicle: 104.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 49.8;Karpas-707: 13.9;MOLT-4: 12.6;REH: 10.0;U-266/70: 10.8;U-698: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.3"	"Group enriched"	"Detected in all"	4	"B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3"	"Low region specificity"	"Detected in all"							"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favourable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	4.1	3.3	3.8	17.6	8.5	9.3	2.6	0.7	12.0	1.0	3.2	10.4	14.6	4.3	0.7	0.9	2.3	2.4	1.5	5.0	4.0	4.2	1.2	5.4	4.7	16.1	4.9	3.1	0.6	0.7	0.0	2.5	0.6	3.1	10.8	2.7	4.4	2.8	104.1	14.2	0.5	6.2	0.9	1.8	20.6	2.0	0.7	2.5	94.9	2.8	2.0	13.2	7.6	0.9	9.0	5.1	1.3	2.2	15.3	2.3	3.7	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.9	0.0	0.0	12.6	3.0	0.0	0.0	10.0	0.0	7.8	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	2.2	0.2	0.0	0.0	0.0	0.0	10.8	0.1	9.4	0.1	2.4	0.1	0.0	1.7	0.0	1.1	2.2	0.3	9.0	1.4	1.2	4.1	6.6	2.3	1.8	1.3	15.3	1.4	5.1	2.1	3.7	3.8	8.5	0.7	6.2	4.0	4.2	4.9	3.1	3.1	2.5
GRXCR1	"DFNB25, PPP1R88"	ENSG00000215203	"Glutaredoxin and cysteine rich domain containing 1"	A8MXD5	4	42893267-43030658	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"seminal vesicle: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040824	Uncertain									"HPA040824: AB_10794863"																		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KIAA1210		ENSG00000250423	KIAA1210	Q9ULL0	X	119078635-119150579	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 24.6;seminal vesicle: 12.3;testis: 19.8"	"Group enriched"	"Detected in some"	9	"Daudi: 2.1;MCF7: 4.1;SK-BR-3: 2.2;U-2 OS: 2.5"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.3"					"Group enriched"	"Detected in some"	5	"basophil: 2.0;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.0"									"HPA000551, HPA048322"	Enhanced									"HPA000551: AB_1079165, HPA048322: AB_2680358"	"unprognostic (2.48e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.26e-4)"	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.7	24.6	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		2.7	0.0		0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8			0.0		0.0	0.1	0.0	0.2	0.2	2.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	2.2	0.2	0.1	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.2	0.3	0.1	0.2	0.0	0.0										
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in some"	81	"BEWO: 12.3;EFO-21: 46.6;RPTEC TERT1: 33.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037989	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA037989: AB_10670536"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0
SLC35F4	"C14orf36, FLJ37712"	ENSG00000151812	"Solute carrier family 35 member F4"	A4IF30	14	57563922-57982194	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 29.5;seminal vesicle: 10.5"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.4;U-87 MG: 6.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043853	Uncertain		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA043853: AB_10963083"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-4)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-2)"		"unprognostic (1.38e-1)"		"unprognostic (1.76e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.03e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (9.23e-2)"	0.1	0.1	1.2	0.1	4.9	0.1	0.1	29.5	1.1	1.0	0.2	0.1	0.5	0.2	1.5	0.2	0.1	0.2	0.5	0.1	0.9	2.2	0.4	0.1	0.1	0.1	0.8	1.2	0.3	0.1	0.1	0.2	0.1	2.9	3.5	0.1	2.4	0.1	10.5	0.1	0.1	0.4	1.1	1.3	0.1	0.1	2.7	0.7	0.0	2.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	4.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.9	29.5	1.1	0.9	2.2	0.8	1.2	2.9	0.7
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 155.4;hTCEpi: 182.5;SiHa: 54.7;THP-1: 46.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	2600000	2600000	"Golgi apparatus"	"Golgi apparatus"	"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	155.4	0.0	11.6	0.0	5.6	0.0	0.7	0.0	0.0	20.8	0.0	30.0	0.0	0.0	0.8	182.5	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.6	0.0	0.0	0.0	31.6	1.2	0.0	0.0	54.7	11.7	0.1	0.2	46.2	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 sigma 3 subunit"	Q96PC3	2	223751686-223838027	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA066782	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA066782: AB_2685720"	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavourable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	1.9	1.4	1.6	5.4	3.0	1.8	1.6	2.2	1.9	1.6	1.8	0.2	50.0	3.1	0.8	64.5	5.8	1.7	7.6	1.0	2.3	1.7	7.0	1.9	5.2	3.8	1.1	1.0	0.8	5.1	3.3	6.8	4.6	0.9	2.5	2.0	1.9	4.1	39.6	0.5	1.6	4.1	0.9	1.0	3.1	6.2	1.1	0.4	0.8	10.5	3.1	5.7	8.1	2.9	8.8	5.3	4.9	0.5	0.7	1.6	0.7	8.9	8.5	1.0	3.2	0.5	0.2	4.6	3.7	0.9	1.9	1.7	55.0	7.0	3.5	3.1	0.5	14.8	2.7	10.2	2.8	5.1	4.3	0.3	13.5	5.6	0.2	1.1	0.4	0.1	11.1	3.4	11.7	1.3	0.5	0.8	1.1	3.8	0.1	0.2	1.2	6.0	1.3	0.0	1.5	17.4	17.6	2.5	0.7	2.0	3.6	1.2	1.7	1.6	0.6	0.3	1.9	1.0	2.9	3.5	3.0	9.6	1.3	0.4	2.0	4.9	0.5	0.4	1.1	0.3	0.8	8.8	0.5	0.4	2.2	3.5	0.4	0.7	1.9	0.7	0.2	5.3	1.6	0.7	1.6	3.0	2.2	1.9	2.3	1.7	1.1	1.0	0.9	0.4
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 29.6;seminal vesicle: 9.5"	"Group enriched"	"Detected in some"	4	"AF22: 6.8;fHDF/TERT166: 6.0;HaCaT: 13.6;LHCN-M2: 16.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.9	0.9	13.0	0.7	20.4	0.7	1.2	0.5	29.6	1.4	0.8	5.5	0.0	1.2	0.9	1.1	1.0	0.7	1.1	1.1	10.4	7.7	0.8	0.7	0.9	0.7	9.3	12.2	3.7	0.7	0.8	0.9	1.3	12.8	1.4	0.9	0.0	1.4	9.5	1.4	0.9	1.0	1.4	7.7	0.8	0.8	1.2	5.6	0.0	1.0	0.0	0.8	1.7	0.3	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.0	13.6	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.0	16.4	0.0	0.0	0.0	1.2	1.2	0.0	0.0	1.0	0.0	1.8	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	13.0	20.4	0.5	17.8	10.4	7.7	9.3	12.2	12.8	5.6
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48614939	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.6;HDLM-2: 9.2;HEK 293: 21.2;LHCN-M2: 10.8;RPTEC TERT1: 22.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enriched"	"Detected in single"	82	"pons and medulla: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	48	"pons and medulla: 6.8"	"Low region specificity"	"Detected in many"			HPA075905			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.5	4.3	0.0	1.6	0.0	0.0	2.5	0.0	0.0	7.7	2.1	0.0	45.4	0.0	2.1	39.2	0.0	0.9	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.2	8.2	1.9	0.8	0.0	0.1	34.6	0.2	0.4	4.0	1.1	49.3	0.0	4.3	2.8	0.0	0.1	0.1	0.0	0.0	5.0	6.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	3.2	0.0	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	20.6	3.2	0.0	0.0	0.0	0.0	9.2	21.2	0.5	0.0	0.0	0.2	0.0	3.1	0.6	0.0	0.0	0.0	1.3	6.1	0.0	10.8	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	22.5	0.5	0.0	0.0	0.3	0.0	3.0	0.2	0.0	5.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621159-48626356	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 77.4;HEK 293: 29.8;HMC-1: 30.6;K-562: 32.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031463			Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA031463: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	0.8	0.1	1.9	0.2	0.0	0.4	0.1	0.3	5.3	16.6	0.1	27.3	0.0	1.4	42.8	0.1	0.4	0.1	0.1	0.1	0.1	15.3	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.5	0.2	1.1	10.4	0.1	0.1	23.5	0.2	0.2	11.3	1.0	3.5	0.2	0.2	2.0	0.1	0.1	0.1	0.1	0.1	2.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	1.3	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	1.6	0.0	8.3	0.2	0.0	1.3	0.0	0.0	77.4	29.8	13.5	0.5	0.0	0.5	0.2	30.6	0.0	0.0	0.0	0.8	0.0	32.8	0.0	1.3	0.0	0.0	0.1	0.0	1.2	0.0	5.2	0.4	13.5	0.0	0.0	0.0	1.0	0.0	8.5	0.1	0.0	0.1	0.0	7.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 19.2"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Group enriched"	"Detected in some"	6	"amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA060584	Enhanced				"Secreted in other tissues"					"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.4	0.1	0.4	0.0	0.1	0.1	4.9	0.1	12.8	0.1	12.0	16.5	0.1	2.0	0.1	0.0	0.1	1.9	1.7	0.1	0.1	0.1	2.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0.0	5.2	0.1	0.7	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1
LCN9		ENSG00000148386	"Lipocalin 9"	Q8WX39	9	135663322-135666422	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7"	"Cell line enriched"	"Detected in some"	15	"BEWO: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060941	Enhanced				"Secreted in male reproductive system"					"HPA060941: AB_2732654"					"unprognostic (7.64e-4)"													0.3	0.0	0.5	0.0	0.5	0.0	0.0	0.2	2.1	0.2	0.0	0.1	17.2	0.0	0.0	5.0	0.0	0.5	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.3	0.9	0.0	0.1	0.0
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.0;kidney: 5.7;seminal vesicle: 7.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.2;HMC-1: 2.6;WM-115: 11.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 8.1"					"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Region enhanced"	"Detected in many"		"cerebellum: 21.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 20.4"	"HPA044307, HPA073521, HPA074382"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavourable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	15.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1		5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.9	0.0	1.5	0.0	0.0	0.0	0.1	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1										
MATN4		ENSG00000124159	"Matrilin 4"	O95460	20	45293445-45308529	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 21.5;pancreas: 27.1;seminal vesicle: 17.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 6.9;SK-MEL-30: 2.2;U-937: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (1.54e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.53e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.63e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.38e-2)"	0.6	0.0	0.1	0.0	0.2	0.1	2.4	0.0	0.2	1.4	0.0	0.0	21.5	0.0	0.6	0.6	0.2	0.1	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.3	0.0	0.1	0.2	0.0	1.9	1.5	17.7	0.0	4.1	0.0	0.0	0.3	0.0	0.4	1.6	0.0	0.2	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.4	0.4	3.1	0.3	0.1	0.3	0.0	0.0	0.0	1.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	6.9	0.3	1.0	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.1	0.3	2.2	0.1	0.6	0.0	0.2	0.9	0.0	0.1	0.1	0.6	0.2	0.2	3.5	0.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597842-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8"	"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 23.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"			"Nuclear speckles, Cytoplasmic bodies"	"Nuclear speckles, Cytoplasmic bodies"	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favourable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	2.5	0.4	3.8	1.5	4.7	0.2	1.8	1.4	2.5	2.5	1.3	1.7	47.8	0.6	3.2	63.1	0.8	2.7	1.3	5.0	3.6	4.3	9.3	17.2	13.7	6.1	6.0	1.0	0.5	1.8	11.4	1.0	4.4	7.0	6.0	1.2	10.7	1.5	123.8	10.3	0.3	1.9	4.2	7.4	0.5	2.2	2.0	2.5	0.4	5.0	0.4	3.7	2.1	1.3	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.7	0.2	0.5	0.1	0.0	0.2	0.0	0.0	23.4	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	3.8	4.7	1.4	2.5	3.6	4.3	6.0	1.0	7.0	2.5
PNMT	PENT	ENSG00000141744	"Phenylethanolamine N-methyltransferase"	P11086	17	39667981-39670475	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 94.6;ductus deferens: 53.7;seminal vesicle: 40.7"	"Cell line enhanced"	"Detected in some"		"HEL: 4.7;K-562: 10.2;NB-4: 20.2;NTERA-2: 3.9;SCLC-21H: 5.5;SH-SY5Y: 5.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 27.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.5"	"Group enriched"	"Detected in many"	5	"B-cells: 1.0;T-cells: 2.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in single"			"CAB017029, HPA043412, HPA051005"	Enhanced									"CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306"	"unprognostic (1.50e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (3.95e-5)"	"unprognostic (4.27e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.87e-2)"	2.3	94.6	3.9	0.8	13.8	1.6	5.4	0.9	3.0	1.3	1.9	1.5	53.7	0.9	1.0	2.7	0.9	1.9	0.8	4.9	1.7	5.4	1.0	0.7	1.6	0.8	9.1	1.5	0.9	0.7	2.4	12.9	2.4	3.6	4.3	0.7	0.9	0.7	40.7	10.5	0.8	1.0	0.8	0.7	0.9	0.9	1.3	2.7	0.0	0.7	0.8	0.7	1.3	1.7	1.0	0.0	0.3	0.3	0.0	2.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.4	4.7	0.1	0.4	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.2	3.9	0.0	0.1	0.0	0.3	0.0	0.0	5.5	5.0	0.0	2.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.4	1.0	0.4	1.5	0.0	0.4	0.0	0.7	0.3	0.0	0.3	0.0	0.0	0.3	3.9	13.8	0.9	3.0	1.7	5.4	9.1	1.5	3.6	2.7
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.1	7.1	0.3	2.6	0.0	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.1	0.0	1.8	0.4	0.1	0.1	5.2	0.0	9.4	0.4	0.8	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.1	0.1	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 31.0;BEWO: 32.9;HaCaT: 43.0;SK-BR-3: 31.6;U-2197: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	19.3	0.0	9.2	31.0	10.7	32.9	1.4	12.7	0.2	0.3	0.9	14.1	0.0	0.5	3.5	43.0	0.1	1.4	0.1	0.0	0.1	0.0	13.7	0.0	0.7	0.0	0.0	6.3	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	1.7	0.0	0.0	0.0	1.0	20.6	0.1	0.7	17.2	31.6	0.1	16.5	0.0	0.1	0.0	0.0	81.7	0.0	0.0	0.0	0.0	16.2	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6
TMEM114		ENSG00000232258	"Transmembrane protein 114"	B3SHH9	16	8537605-8590193	"Disease related genes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 60.1;seminal vesicle: 24.7"	"Group enriched"	"Detected in some"	5	"NTERA-2: 1.5;U-2 OS: 2.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"hypothalamus: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 9.6"															"unprognostic (3.72e-5)"	"unprognostic (2.26e-1)"	"unprognostic (3.98e-3)"		"unprognostic (7.33e-2)"			"unprognostic (2.19e-1)"			"unprognostic (2.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"		0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.0	60.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.4	0.0	0.0	0.0	24.7	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	8.3	0.1	0.0	0.3	0.0
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell line enhanced"	"Detected in many"		"A549: 121.0;BJ hTERT+: 222.0;RPTEC TERT1: 105.0;U-87 MG: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		1700000	1700000	Cytosol	Cytosol	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: "	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.3	121.0	13.6	19.3	58.9	16.0	36.3	13.0	222.0	19.1	24.8	5.6	12.3	0.0	6.0	21.7	5.7	14.8	12.9	15.2	4.8	13.6	6.8	18.2	16.4	84.4	0.0	0.0	14.9	9.7	27.3	7.3	26.9	0.0	4.5	21.1	0.2	20.0	9.2	22.7	0.1	20.9	8.7	10.1	105.0	65.4	10.2	22.7	90.9	0.1	9.5	0.0	10.2	21.2	18.9	8.8	1.7	14.1	12.5	13.7	33.8	99.9	0.0	11.3	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Group enriched"	"Detected in some"	5	"A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	33.8	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.6	0.0	63.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	4.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.8	0.2	4.1	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9
C3orf36	FLJ22173	ENSG00000221972	"Chromosome 3 open reading frame 36"	Q3SXR2	3	133928145-133929812	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"lung: 8.2;seminal vesicle: 14.7"	"Group enriched"	"Detected in some"	5	"EFO-21: 6.4;HeLa: 1.6;TIME: 5.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046432	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA046432: AB_2679664"	"unprognostic (3.56e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-3)"	"unprognostic (4.64e-4)"	"unprognostic (5.05e-3)"	"unprognostic (8.18e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	1.1	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.2	0.7			0.2	1.3	0.0	0.6	1.1	0.8	0.7	0.0	0.0	1.9	0.0	8.2	0.1	0.0		0.0	0.7	1.6	0.2	0.1		2.3	0.3		0.4	14.7	0.0	0.1	1.4	1.0	0.0	1.5	0.8	0.0			2.7		0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL20	"IL-20, IL10D, ZCYTO10"	ENSG00000162891	"Interleukin 20"	Q9NYY1	1	206865354-206869223	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"seminal vesicle: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.8;hTCEpi: 1.0;SiHa: 5.8;SK-MEL-30: 2.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025802	Uncertain				"Secreted to blood"					"CAB025802: "	"unprognostic (3.08e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.82e-1)"		"unprognostic (1.16e-2)"		"unprognostic (6.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"		"unprognostic (3.38e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.71e-1)"	4.6	2.2	0.2	0.2	0.2	0.0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.8	0.2	0.4	0.7	1.3	0.2	0.2	0.0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.3	0.0	0.2	0.6	19.5	0.2	3.8	0.2	3.2	0.2	0.2	0.0	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.8	0.0	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139746	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"salivary gland: 1246.7;seminal vesicle: 651.3"	"Cell line enriched"	"Detected in single"	330	"T-47d: 123.4"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.5;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 2.6"									"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"	89000000	89000000			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	0.4	0.1	0.1	0.0	0.2	0.0	144.4	0.2	0.1	0.2	0.1	0.0	219.3	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.6	0.0	0.2	0.0	0.1	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1246.7	651.3	0.2	7.7	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	49.3	1.1	1.8	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	123.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.0
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.8;PC-3: 14.9;SCLC-21H: 13.9;U-266/70: 33.3;U-266/84: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favourable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	3.0	0.0	0.0	0.2	14.9	0.1	0.0	6.6	0.0	0.0	13.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	33.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell line enhanced"	"Detected in many"		"A549: 19.9;BEWO: 34.7;MCF7: 11.5;RPMI-8226: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"											"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.7	19.9	5.9	0.0	0.2	0.0	34.7	0.7	0.6	1.0	1.7	4.4	0.2	0.0	0.2	0.1	5.8	0.2	0.6	1.5	5.6	0.9	0.2	0.1	5.9	0.0	0.3	0.0	0.1	2.4	2.3	0.1	1.8	0.4	0.0	0.6	11.5	2.7	0.1	2.0	0.0	1.3	0.0	17.4	0.0	4.2	0.1	0.2	4.1	0.4	0.5	0.1	0.0	0.0	0.8	0.7	0.2	0.0	5.5	2.1	0.0	1.5	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150988-34358008	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 31.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"eosinophil: 8.1;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA020065: AB_1844459, HPA030699: AB_2673576"	"unprognostic (3.00e-1)"	"prognostic unfavourable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favourable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	3.1	13.7	4.8	2.7	6.7	3.2	2.2	5.0	5.8	8.0	8.5	10.6	18.2	11.7	7.4	6.3	4.4	4.1	3.2	13.0	4.7	3.9	8.4	8.0	2.9	2.7	9.0	1.5	2.8	2.2	0.3	2.8	8.1	15.8	4.5	3.6	7.5	8.7	31.6	19.4	5.6	20.2	3.6	20.2	1.2	3.0	3.1	7.7	6.4	2.1	3.5	2.8	3.4	5.0	0.0	2.8	8.1	0.4	0.0	0.1	0.1	4.0	12.1	4.9	1.3	1.3	0.1	4.9	2.4	1.9	2.1	4.1	2.9	3.0	0.1	4.1	3.0	7.9	2.7	2.8	1.8	0.1	6.7	0.0	7.1	12.8	0.7	6.5	0.9	0.7	1.5	4.3	1.9	0.0	1.3	0.3	1.3	10.1	0.2	7.8	6.1	6.6	1.2	2.9	4.6	7.7	9.7	6.2	5.1	6.0	18.8	4.8	4.0	2.8	0.6	2.4	0.4	7.5	4.3	0.7	0.3	0.1	5.5	1.8	7.3	0.0	0.1	8.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.1	0.1	4.8	6.7	5.0	5.6	4.7	3.9	9.0	1.5	15.8	7.7
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 14.6;U-937: 8.5"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA040470	Enhanced									"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.6	4.8	16.5	1.5	15.7	21.3	0.7	22.8	34.0	0.5	0.7	5.3	30.1	5.4	0.5	1.0	0.9	0.7	0.9	2.0	12.4	9.7	2.3	2.6	0.8	2.5	9.6	12.1	0.5	1.9	13.0	2.7	1.1	12.1	0.8	0.8	3.3	0.8	35.8	3.6	0.6	3.3	0.5	4.2	1.2	1.2	23.0	4.7	0.0	0.9	0.0	1.5	0.7	0.3	0.1	0.0	0.6	0.1	1.2	4.2	1.1	0.0	0.0	0.2	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	1.6	0.2	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	1.4	0.9	0.1	0.1	0.0	0.0	0.0	0.0	14.6	0.7	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.3	8.5	0.5	0.6	0.1	0.1	1.5	0.0	3.5	0.1	2.1	4.2	0.0	0.1	3.9	1.8	0.2	1.2	0.0	0.0	0.1	1.1	16.5	15.7	22.8	18.8	12.4	9.7	9.6	12.1	12.1	4.7
ADGRD2	"GPR144, PGR24"	ENSG00000180264	"Adhesion G protein-coupled receptor D2"	Q7Z7M1	9	124451425-124478589	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 2.8;pituitary gland: 7.2;seminal vesicle: 5.8"	"Cell line enriched"	"Detected in single"	15	"SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	4	"hypothalamus: 0.7;midbrain: 1.9;pons and medulla: 0.7"												"unprognostic (7.39e-4)"	"unprognostic (1.34e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.23e-6)"		"unprognostic (1.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.63e-2)"		"unprognostic (2.25e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-1)"	0.0	0.6	0.1	0.0	0.1	0.0	2.8	0.1	0.0	0.2	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	7.2	0.0		0.3	0.0		0.0	5.8	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.3;HUVEC TERT2: 35.2;RPMI-8226: 13.3;TIME: 19.0;U-138 MG: 12.7;U-266/84: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.6	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.4	0.3	1.5	0.8	0.0	0.7	0.3	0.7	0.0	4.7	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.7	3.5	10.3	35.2	8.5	0.0	1.2	0.0	0.0	0.2	0.1	2.4	0.0	0.1	13.3	0.7	0.1	0.0	0.1	0.6	0.0	0.3	0.0	0.3	19.0	12.7	0.9	0.3	1.0	0.5	14.9	0.0	2.6	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 160.2;gallbladder: 147.0;seminal vesicle: 159.4"	"Cell line enhanced"	"Detected in some"		"A549: 31.4;RPTEC TERT1: 75.0;RT4: 44.3;T-47d: 160.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	22000	22000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	0.9	0.9	0.9	23.0	0.9	0.0	5.3	0.9	0.9	52.8	58.8	1.3	160.2	36.5	4.8	51.9	4.0	23.7	147.0	0.9	0.9	0.9	3.3	0.9	19.0	0.0	0.8	0.0	4.0	59.2	0.0	11.3	1.6	0.1	18.8	97.7	0.0	70.0	159.4	0.9	1.1	62.2	3.3	0.8	0.9	107.6	0.9	0.0	0.1	1.1	20.0	97.7	13.2	3.7	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.1	4.7	0.0	0.0	0.0	3.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	10.4	0.0	1.3	0.0	0.0	0.0	0.0	5.2	0.1	0.2	0.0	18.7	0.1	0.0	0.6	75.0	44.3	0.2	0.2	0.0	12.0	0.0	160.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.8	0.0	0.1	0.0
AL022318.4		ENSG00000284554			22	39014363-39033276	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"seminal vesicle: 42.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.9;HHSteC: 3.7;HSkMC: 2.1;Karpas-707: 7.5;NB-4: 1.7"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA055116	Uncertain									"HPA055116: AB_2682701"																		3.8	1.2	0.0	4.7	0.0	1.1	1.1	0.0	0.7	6.9	2.9	0.3	9.2	0.6	5.7	7.7	6.2	2.7	4.0	1.9	0.0		1.1	1.9	3.2	8.6	0.0	0.0	8.8	1.8	0.6	0.0	1.7	0.0	6.6	1.8	3.7	3.2	42.5	1.3	0.6	2.3	5.3	0.1	11.0	0.6	16.1	0.0	4.9	2.1	5.2	16.1	7.1	1.0	5.4	1.9	1.5	3.2	1.1	6.1	0.1	0.0	0.8	0.0	0.0	0.9	0.8	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.5	0.0	1.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	2.1	0.0	0.7	0.0	0.0	0.1	7.5	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	1.5	4.8	3.2	2.8	5.4	4.5	6.1	0.2	5.4	2.7	3.0	0.0	1.1	3.1	1.9	5.2	0.1										
AMELX	"AIH1, AMG"	ENSG00000125363	"Amelogenin, X-linked"	Q99217	X	11293413-11300761	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4"	"Cell line enhanced"	"Detected in single"		"K-562: 1.3"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.9"	"Region enhanced"	"Detected in single"		"amygdala: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"								"unprognostic (1.76e-1)"									"unprognostic (1.00e-1)"		"unprognostic (2.00e-1)"				0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.3	3.5	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.6	0.5	0.5	0.0	0.7	0.0	0.0
ANO4	"FLJ34221, FLJ34272, FLJ35277, TMEM16D"	ENSG00000151572	"Anoctamin 4"	Q32M45	12	100717526-101128641	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.3;brain: 19.2;seminal vesicle: 14.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 14.1;LHCN-M2: 6.8;SK-MEL-30: 10.9;TIME: 22.4;WM-115: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053412	Uncertain									"HPA053412: AB_2682140"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.54e-2)"	"prognostic favourable (5.48e-5)"	"unprognostic (1.16e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.41e-1)"	0.9	20.3	10.3	0.6	16.7	0.6	0.7	2.8	13.0	13.3	0.8	17.2	1.4	1.1	7.9	1.2	0.7	1.0	0.8	0.8	9.5	5.8	0.8	0.6	0.7	0.6	10.9	8.6	13.8	1.6	0.8	2.2	0.7	12.1	8.7	0.9	0.0	3.6	14.0	0.6	0.7	0.9	1.5	4.4	0.6	0.6	2.1	19.2	0.0	0.8	0.0	1.3	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.8	1.1	0.0	4.9	4.4	4.2	2.0	0.0	0.0	0.0	0.0	14.1	0.2	5.1	4.2	3.9	0.0	0.0	0.0	2.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	10.9	0.0	0.0	22.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	16.7	2.8	13.0	9.5	5.8	10.9	8.6	12.1	19.2
ANXA9	ANX31	ENSG00000143412	"Annexin A9"	O76027	1	150982017-150995634	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 62.0;seminal vesicle: 78.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 12.0;CAPAN-2: 14.4;Hep G2: 14.5;MCF7: 19.3;T-47d: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028404, HPA028698"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"HPA028404: AB_10599190, HPA028698: AB_10600227"	"unprognostic (4.06e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.93e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (8.74e-6)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.72e-2)"	2.4	1.1	1.2	0.9	1.2	0.3	2.6	1.3	2.5	2.3	0.9	0.6	62.0	1.4	6.0	11.6	10.7	2.3	12.5	1.9	1.4	1.0	12.1	15.8	1.2	0.5	1.8	0.8	1.8	32.0	9.9	1.2	0.7	1.3	4.1	0.0	1.2	2.5	78.1	0.9	18.9	1.2	0.9	3.2	1.0	1.3	3.6	0.6	1.3	10.4	9.1	21.1	4.5	4.4	0.5	3.8	2.5	3.1	0.1	0.8	0.8	3.9	0.9	1.4	1.4	0.0	0.0	4.1	0.3	0.2	0.0	0.0	12.0	14.4	0.1	0.8	0.0	2.4	0.0	0.2	0.0	1.2	1.4	2.0	1.4	14.5	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.9	4.4	0.0	19.3	0.1	1.0	0.3	0.2	0.9	0.2	4.7	0.0	5.6	2.1	1.2	0.8	9.9	0.5	48.0	1.2	1.5	0.3	0.4	0.2	0.2	1.3	4.0	6.2	2.1	1.3	1.1	0.0	3.1	1.8	0.1	1.8	0.8	0.5	0.3	0.5	3.8	0.1	0.8	0.2	2.5	0.1	0.4	0.0	0.0	0.8	1.2	1.2	1.3	0.9	1.4	1.0	1.8	0.8	1.3	0.6
APOBEC3C	"APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI"	ENSG00000244509	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3C"	Q9NRW3	22	39014083-39020352	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 114.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB033048, HPA071523"	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"CAB033048: AB_2057401, HPA071523: AB_2686409"	"unprognostic (1.79e-3)"	"prognostic favourable (1.08e-5)"	"unprognostic (4.32e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (8.91e-10)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.52e-3)"	13.3	28.0	2.3	15.6	3.4	9.2	8.0	1.1	2.0	21.4	13.1	4.2	27.5	4.5	18.2	23.5	19.6	20.9	13.8	13.0	2.2	2.0	6.3	4.5	11.7	20.9	3.3	2.0	26.4	5.3	0.7	3.3	7.7	3.2	20.7	12.0	12.9	12.3	114.8	3.4	6.9	11.8	17.2	4.2	32.2	8.1	45.6	2.4	16.2	8.7	17.0	45.5	21.8	12.7	48.1	19.7	49.3	42.6	35.2	61.3	26.2	10.6	10.5	1.8	20.6	11.6	24.1	9.0	7.8	15.3	11.6	15.5	10.0	12.1	31.6	5.2	15.4	10.9	1.8	33.1	11.3	11.9	9.0	30.4	0.5	8.2	12.6	19.7	30.6	26.1	19.2	15.1	3.8	6.4	18.5	40.3	23.1	0.1	7.9	10.7	2.7	23.1	13.8	4.8	26.3	7.6	14.1	0.5	1.4	11.3	0.0	5.7	0.1	7.3	3.3	6.2	10.7	3.3	3.3	10.9	11.2	2.6	19.2	12.8	16.2	13.6	20.3	49.3	61.3	40.2	42.2	44.6	33.6	54.6	19.7	48.1	11.5	41.1	2.7	35.2	42.6	16.7	30.5	26.2	2.3	3.4	1.1	2.0	2.2	2.0	3.3	2.0	3.2	2.4
ARC	"Arg3.1, KIAA0278"	ENSG00000198576	"Activity regulated cytoskeleton associated protein"	Q7LC44	8	142611044-142614472	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.8;seminal vesicle: 67.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.8;HEK 293: 8.4;SCLC-21H: 20.0;U-2 OS: 9.7;U-87 MG: 10.9"	"Cancer enriched"	"Detected in many"	12	"glioma: 36.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 48.9;basal ganglia: 51.6;cerebral cortex: 144.6;hippocampal formation: 99.8;olfactory region: 50.5"	"Group enriched"	"Detected in many"	7	"basal ganglia: 25.3;cerebral cortex: 87.7;hippocampal formation: 55.8;olfactory region: 47.5"	"HPA056430, CAB079013"		Supported	Approved	Vesicles,Microtubules				"Vesicles, Microtubules"	"Vesicles, Microtubules"	"CAB079013: , HPA056430: AB_2683130"	"unprognostic (1.40e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.87e-4)"	"unprognostic (6.83e-2)"	"unprognostic (8.12e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.43e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.35e-2)"	18.1	15.9	6.1	1.0	6.5	0.7	1.0	0.8	17.0	1.5	0.9	4.2	11.8	0.8	1.4	1.8	0.9	1.2	3.5	0.5	13.9	7.1	1.5	0.7	2.7	0.4	2.4	2.1	0.5	6.2	0.4	25.8	1.8	4.0	1.0	0.6	0.0	0.5	67.7	0.5	3.5	0.7	0.9	1.2	0.7	2.1	0.6	1.1	0.0	1.5	0.8	1.9	0.6	1.5	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.1	0.3	6.8	0.1	0.7	0.0	1.4	0.0	0.3	0.1	0.1	0.0	0.0	0.9	0.2	0.1	0.4	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	3.1	1.5	0.0	0.6	0.0	0.0	0.0	20.0	4.7	0.4	0.0	0.2	0.0	0.1	0.0	1.1	9.7	0.7	0.2	1.8	0.0	0.0	10.9	0.0	2.9	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	6.5	0.8	17.0	13.9	7.1	2.4	2.1	4.0	1.1
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11137543-11665701	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 57.3;seminal vesicle: 58.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.8;ASC TERT1: 19.2;HEL: 18.9;HMC-1: 13.3;HSkMC: 18.9;K-562: 13.7;RT4: 10.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	920000	920000	Cytosol	Cytosol	"HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253"	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	9.4	1.2	16.7	2.6	10.0	0.7	6.3	0.6	2.9	9.5	11.7	4.1	57.3	2.0	10.2	9.0	4.1	7.6	5.4	3.6	5.6	4.3	6.0	1.1	8.7	1.2	2.3	3.6	15.1	1.9	1.1	6.6	6.2	2.7	24.8	3.7	3.2	2.5	58.8	8.0	2.3	4.2	12.1	3.1	5.0	4.1	2.2	3.3	0.0	25.9	3.1	1.4	14.3	8.0	1.3	0.2	1.0	0.9	0.0	0.1	2.7	0.0	0.0	1.3	0.0	14.8	19.2	0.3	0.1	0.3	0.7	0.5	0.1	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.7	0.0	0.2	18.9	0.0	0.0	5.4	0.0	13.3	18.9	0.0	1.3	0.0	0.3	13.7	6.4	0.8	0.0	0.0	0.0	0.3	0.2	0.0	6.3	8.0	4.5	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	3.8	0.1	0.3	0.0	0.0	0.1	0.0	2.0	1.0	0.3	0.5	0.0	0.9	0.0	1.3	0.0	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.7	0.2	0.0	2.7	16.7	10.0	0.6	2.9	5.6	4.3	2.3	3.6	2.7	3.3
ARHGEF37	FLJ41603	ENSG00000183111	"Rho guanine nucleotide exchange factor 37"	A1IGU5	5	149551947-149634968	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 66.1;seminal vesicle: 73.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.9;HaCaT: 18.2;hTCEpi: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 9.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.0"	"Region enhanced"	"Detected in some"		"cerebellum: 9.5"	"Low region specificity"	"Detected in all"			"HPA043885, HPA053487"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA043885: AB_2678715, HPA053487: AB_2682167"	"unprognostic (3.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.16e-2)"	"prognostic favourable (6.85e-4)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.10e-1)"	2.5	2.7	10.8	1.9	13.2	3.0	16.8	6.7	7.1	4.0	10.2	17.5	66.1	4.5	4.4	9.5	7.6	7.4	4.6	6.4	12.8	9.5	4.6	1.4	4.3	1.0	19.1	5.8	2.2	7.0	29.6	5.3	3.6	12.3	16.0	5.2	12.0	23.2	73.8	11.9	29.3	4.8	7.0	31.7	1.0	11.7	4.8	15.1	0.7	2.1	4.8	3.4	6.4	5.4	0.7	1.1	9.0	1.2	0.2	0.8	0.0	2.9	1.1	0.8	3.6	0.2	0.4	2.1	0.4	0.6	0.6	0.6	0.0	3.9	0.4	9.9	0.4	18.2	0.3	1.8	1.2	0.8	0.9	0.3	1.8	0.2	0.7	0.0	0.5	0.5	24.2	1.8	2.4	2.9	0.4	0.7	0.0	0.4	0.5	0.5	0.2	2.2	0.3	0.4	0.0	4.0	1.5	1.5	3.5	2.2	0.2	0.3	5.4	0.1	2.3	0.2	0.7	0.0	0.5	0.5	1.0	0.3	0.7	0.1	2.5	9.0	0.9	0.5	0.4	1.2	0.5	0.2	0.3	0.3	0.3	0.7	0.8	0.6	4.9	0.2	0.5	1.1	0.2	0.0	10.8	13.2	6.7	7.1	12.8	9.5	19.1	5.8	12.3	15.1
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 43.4;HDLM-2: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA001562	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	41.5	21.5	9.5	41.0	7.1	9.4	30.2	3.0	8.0	30.0	16.2	15.3	36.4	5.0	34.9	28.6	31.4	38.1	33.4	31.8	6.5	6.9	19.4	36.1	42.8	4.6	13.5	6.5	23.1	16.0	15.1	12.4	65.1	9.4	30.4	15.0	8.1	12.1	138.4	13.2	39.5	11.4	76.1	13.0	5.4	31.6	10.7	12.4	1.5	45.5	37.3	7.4	38.3	33.8	0.3	2.2	6.1	8.1	0.0	0.4	0.8	6.6	0.4	13.4	2.8	1.3	3.4	43.4	4.8	3.9	4.1	9.9	8.9	5.0	0.1	2.2	0.3	3.7	8.0	1.3	6.8	31.7	7.7	0.5	3.9	3.1	24.6	2.8	7.5	6.0	21.6	11.5	26.9	0.8	3.1	25.3	0.6	0.8	8.5	1.8	9.6	2.8	2.5	8.9	5.7	0.5	0.9	6.0	6.1	6.2	11.2	18.8	6.5	2.0	0.8	1.2	6.4	4.0	2.1	20.0	8.4	2.2	4.0	1.5	3.5	6.1	0.9	0.0	0.4	5.5	0.4	0.1	0.1	0.0	2.2	0.3	0.0	0.0	0.3	0.0	8.1	1.1	0.0	0.8	9.5	7.1	3.0	8.0	6.5	6.9	13.5	6.5	9.4	12.4
ATP1A4	ATP1AL2	ENSG00000132681	"ATPase Na+/K+ transporting subunit alpha 4"	Q13733	1	160151570-160186977	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 13.1;seminal vesicle: 19.0;testis: 35.8"	"Group enriched"	"Detected in some"	11	"BEWO: 10.5;HDLM-2: 26.2;RT4: 31.7"	"Group enriched"	"Detected in some"	8	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (1.33e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.09e-2)"	"prognostic favourable (2.20e-4)"	0.4	0.3	0.4	0.8	0.3	0.0	2.2	0.4	0.3	0.3	0.3	0.0	11.2	0.0	0.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.2	0.2	0.3	3.8	0.3	0.0	0.2	0.2	0.0	0.3	13.1	0.0	0.6	0.0	0.4	1.2	19.0	3.2	0.3	0.5	1.6	0.3	1.1	0.3	35.8	0.0	0.9	0.2	0.2	1.6	8.9	5.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.0	0.0	0.0
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677342-28682939	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 46.8;seminal vesicle: 52.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 42.8;SK-MEL-30: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"				Vesicles	Vesicles	"HPA010819: AB_2668371, HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favourable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	2.0	24.7	6.7	1.8	6.9	3.0	13.6	2.2	6.3	3.9	2.3	12.9	15.5	1.1	10.1	2.0	1.1	2.8	3.0	22.8	6.7	6.4	11.2	12.9	5.7	3.1	12.0	2.9	46.8	3.9	7.4	4.5	20.9	10.5	6.5	2.8	30.4	3.8	52.4	1.2	2.7	1.1	12.7	10.8	9.0	2.3	4.8	7.9	0.1	0.6	2.1	1.3	13.8	11.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.2	10.8	1.1	0.6	1.3	0.0	6.5	2.6	0.9	4.2	2.7	42.8	4.5	0.1	1.6	1.9	3.2	2.6	0.4	1.9	2.6	6.0	10.1	1.6	16.2	1.5	0.6	13.4	1.0	0.6	2.8	0.4	0.6	5.7	4.9	0.8	17.8	0.0	0.7	19.6	2.7	0.1	2.0	0.9	3.4	10.4	1.8	1.4	3.5	20.8	51.1	6.1	0.7	0.0	2.8	2.1	4.5	1.3	0.1	3.7	0.0	0.2	2.3	17.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.7	6.9	2.2	4.8	6.7	6.4	12.0	2.9	10.5	7.9
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	"Cell line enhanced"	"Detected in many"		"A549: 18.3;MCF7: 9.2;SH-SY5Y: 15.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favourable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	1.1	5.6	12.7	0.8	15.0	0.7	1.7	11.6	12.7	28.0	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32.0	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0.0	18.3	4.9	0.0	1.9	4.5	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.8	1.0	2.9	6.7	0.0	0.0	4.5	0.0	1.1	0.0	0.5	0.4	0.0	2.8	7.5	2.8	5.6	0.0	0.0	0.0	7.0	9.2	0.6	0.1	1.8	3.1	0.1	2.7	0.1	3.5	0.1	0.2	15.3	0.2	2.5	2.5	1.9	0.0	0.0	3.9	3.1	0.1	3.3	0.0	0.0	0.0	1.5	0.0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15.0	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2
C19orf85		ENSG00000283567	"Chromosome 19 open reading frame 85"		19	55463002-55464707	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"lung: 1.7;seminal vesicle: 1.3;testis: 1.1"	"Cell line enriched"	"Detected in single"	83	"NTERA-2: 15.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257159-150265078	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1"	"Group enriched"	"Detected in some"	18	"AF22: 28.0;AN3-CA: 16.6;NTERA-2: 21.8;SK-MEL-30: 55.8"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.1	0.3	4.6	0.2	5.2	0.9	0.3	1.4	6.8	0.1	1.7	10.8	0.1	0.3	0.1	0.5	1.6	1.3	0.7	4.4	6.4	4.1	0.3	6.3	0.2	0.2	11.3	3.2	1.4	0.3	0.8	0.1	0.3	4.4	3.2	0.7	29.4	0.6	16.5	24.1	3.7	0.6	0.5	20.9	0.3	0.8	0.5	2.7	0.1	0.9	0.1	0.1	0.2	0.1	2.8	2.2	2.1	2.0	0.2	1.6	0.2	0.2	0.0	28.0	16.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	21.8	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	55.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.2	0.1	0.1	0.1	0.0	0.0	0.9	1.3	1.6	2.0	0.6	2.0	1.0	1.2	0.2	2.8	1.2	1.3	2.1	0.2	0.5	2.2	0.0	0.2	4.6	5.2	1.4	4.7	6.4	4.1	11.3	3.2	4.4	2.7
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747445-132754403	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 17.4;seminal vesicle: 15.7"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 23.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA056288: AB_2683086"	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favourable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.3	0.7	3.4	5.6	3.5	0.3	0.3	8.4	4.7	1.2	5.8	3.5	17.4	7.8	0.2	0.7	0.5	0.8	5.2	0.6	3.9	2.6	3.8	0.3	0.7	1.7	3.9	0.5	0.3	7.4	0.4	0.9	0.5	4.1	1.7	6.5	1.5	8.4	15.7	0.7	0.7	8.9	0.4	7.2	0.8	5.5	1.4	3.9	7.0	0.8	0.7	2.1	2.4	0.3	0.3	0.1	0.7	0.1	0.2	2.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	23.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.3	0.1	2.7	0.3	2.1	2.1	0.0	0.3	1.8	0.9	0.3	0.2	0.1	0.1	2.7	0.3	3.4	3.5	8.4	2.8	3.9	2.6	3.9	0.5	4.1	3.9
CCNO	"CCNU, FLJ22422, UDG2, UNG2"	ENSG00000152669	"Cyclin O"	P22674	5	55231152-55233680	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.1;epididymis: 18.2;seminal vesicle: 23.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.5;T-47d: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA050090	Uncertain									"HPA050090: AB_2681011"	"unprognostic (3.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-2)"	"prognostic favourable (6.78e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.18e-3)"	"prognostic favourable (7.60e-4)"	"unprognostic (3.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.03e-2)"	"prognostic favourable (5.10e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.88e-3)"	0.7	0.8	1.3	0.8	7.2	0.6	0.7	1.7	4.5	1.9	1.2	1.3	28.1	1.4	1.1	18.2	0.9	4.0	3.5	0.6	1.3	2.0	2.2	0.7	1.3	0.8	0.1	1.6	1.4	9.5	3.0	5.4	0.8	4.3	1.8	0.5	1.6	6.5	23.2	0.5	3.1	2.1	0.6	0.1	0.6	5.3	12.2	0.1	0.0	7.4	0.8	0.9	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.3	3.8	0.0	1.4	0.3	0.0	6.5	0.0	0.0	0.5	0.6	0.0	3.9	0.0	2.7	0.0	3.0	0.1	0.0	0.0	0.0	5.0	0.1	2.8	0.4	0.0	0.4	1.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.1	0.5	5.4	1.9	0.4	0.1	1.3	0.9	2.9	0.0	4.6	1.2	1.0	8.8	0.5	0.3	0.0	3.1	3.6	1.6	3.4	1.8	0.0	2.3	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	7.2	1.7	4.5	1.3	2.0	0.1	1.6	4.3	0.1
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816954	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 142.1;seminal vesicle: 53.7"	"Cell line enhanced"	"Detected in some"		"AF22: 22.6;ASC diff: 27.9;ASC TERT1: 10.8;HAP1: 8.0;NTERA-2: 8.4"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"memory CD4 T-cell: 4.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036573: , HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	31.9	6.2	9.3	1.7	11.2	0.8	9.9	7.6	9.4	3.4	1.5	3.7	36.4	1.0	3.1	42.6	1.8	4.9	3.7	7.6	7.3	9.0	1.7	142.1	3.9	2.3	6.5	5.5	8.7	4.7	1.0	6.5	17.7	14.5	4.0	1.3	19.2	2.8	53.7	3.5	1.1	1.1	2.6	5.3	1.8	1.2	5.0	4.3	0.0	2.8	2.5	1.6	2.4	2.1	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	22.6	0.0	27.9	10.8	0.1	0.6	0.2	2.2	2.1	0.0	0.0	0.0	0.0	0.2	0.0	8.0	0.0	3.1	0.0	3.9	0.7	0.0	0.6	0.1	0.0	0.0	4.1	0.0	0.3	0.0	2.9	0.0	0.0	2.5	0.0	0.5	0.1	8.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	9.3	11.2	7.6	9.4	7.3	9.0	6.5	5.5	14.5	4.3
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favourable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	12.7	10.4	23.4	14.2	4.8	10.3	10.2	17.9	8.6	11.5	12.4	25.4	28.3	33.4	18.5	7.0	15.4	14.3	9.4	14.2	20.9	6.6	61.9	8.7	13.0	1.5	31.6	11.8	5.3	2.0	14.5	10.3	13.6	31.3	29.4	15.1	6.6	46.9	15.5	23.7	9.4	28.6	21.9	17.5	10.6	17.0	14.8	15.7	14.7	10.2	4.3	27.5	10.3	9.1	16.6	14.1	8.0	16.4	6.6	11.8	47.6	6.1	23.8	19.4	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Group enriched"	"Detected in some"	20	"A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5
CPAMD8	"K-CAP, KIAA1283, VIP"	ENSG00000160111	"C3 and PZP like, alpha-2-macroglobulin domain containing 8"	Q8IZJ3	19	16892947-17026815	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 19.3;retina: 23.7;seminal vesicle: 30.5"	"Group enriched"	"Detected in some"	7	"BEWO: 14.4;EFO-21: 9.3;T-47d: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in single"			"HPA031327, HPA031328, HPA031329, HPA031330"	Uncertain		Uncertain	"Focal adhesion sites"	"Secreted to blood"	180000	180000	"Focal adhesion sites"	"Focal adhesion sites"	"HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788"	"unprognostic (4.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-2)"	3.1	1.3	1.0	0.4	2.3	0.2	3.6	0.6	2.3	5.3	0.4	2.9	6.5	0.2	1.5	8.2	0.6	0.6	0.4	7.0	1.2	1.3	8.9	0.5	11.5	1.5	4.9	0.4	0.6	0.4	3.5	2.0	3.1	5.1	19.3	0.0	23.7	1.1	30.5	1.7	0.4	0.4	0.4	5.6	1.1	0.1	0.9	2.8	0.9	11.6	1.4	0.4	1.2	1.4	0.2	0.0	0.6	1.5	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	9.3	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.2	0.5	0.0	1.4	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.4	0.0	25.2	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	2.3	0.6	2.3	1.2	1.3	4.9	0.4	5.1	2.8
CPNE6		ENSG00000100884	"Copine 6"	O95741	14	24070837-24078100	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;seminal vesicle: 20.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;SK-MEL-30: 1.1;U-266/84: 4.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031636, HPA076665"	Enhanced									"HPA031636: AB_10601203, HPA076665: "	"unprognostic (1.02e-2)"	"unprognostic (3.26e-4)"	"unprognostic (1.64e-1)"	"unprognostic (5.66e-5)"	"unprognostic (3.51e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.71e-1)"	1.3	1.5	36.3	1.4	25.1	1.4	1.1	19.1	41.8	1.2	1.5	8.6	1.2	4.8	1.2	2.6	3.7	1.3	1.2	1.4	34.8	16.0	7.9	4.7	1.2	1.2	11.4	20.5	1.3	1.1	1.1	2.7	1.1	20.1	3.5	1.9	2.4	1.2	20.8	1.1	1.2	5.8	1.6	5.1	1.2	1.2	1.3	5.6	0.0	1.2	0.0	1.1	1.5	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	36.3	25.1	19.1	33.2	34.8	16.0	11.4	20.5	20.1	5.6
CPNE7		ENSG00000178773	"Copine 7"	Q9UBL6	16	89575768-89597246	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.5;epididymis: 26.2;seminal vesicle: 21.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 42.6;TIME: 23.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043359	Uncertain									"HPA043359: AB_10794884"	"unprognostic (6.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (9.52e-6)"	"unprognostic (1.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (7.22e-4)"	0.4	0.9	9.5	1.4	6.4	1.3	1.6	0.0	14.2	1.7	0.8	3.3	34.5	4.8	0.9	26.2	1.6	1.6	4.4	0.7	8.0	14.6	3.3	0.9	1.4	0.9	4.0	9.3	0.7	1.1	0.8	11.0	0.6	4.1	1.9	0.4	0.7	2.0	21.9	0.2	2.3	2.8	0.5	0.7	1.0	4.5	2.7	1.0	1.7	0.6	0.0	0.8	1.4	0.8	0.0	0.0	0.2	0.0	1.2	8.5	0.4	0.0	9.8	0.1	0.1	16.7	17.4	0.1	4.2	1.7	5.9	4.6	9.7	8.2	0.0	3.8	1.6	6.6	6.1	0.2	2.0	2.3	4.8	0.1	7.3	0.1	42.6	0.0	1.6	6.8	0.4	3.1	11.7	0.1	10.3	0.1	14.1	1.4	3.0	1.8	6.4	7.5	0.1	0.0	6.7	0.8	0.0	5.5	0.0	1.4	2.0	0.4	1.8	1.2	23.1	11.5	0.0	7.0	0.0	0.0	0.0	1.8	11.3	6.7	4.7	0.0	0.0	0.2	1.1	0.0	8.5	0.0	2.0	3.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.3	0.4	9.5	6.4	0.0	14.2	8.0	14.6	4.0	9.3	4.1	1.0
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;HUVEC TERT2: 8.7;SCLC-21H: 5.8;SK-MEL-30: 9.6;TIME: 11.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008175	Enhanced				"Secreted to extracellular matrix"	360000000	360000000			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favourable (1.51e-4)"	4.5	1.4	6.2	1.6	7.2	0.8	2.0	7.2	27.3	3.9	6.0	3.8	4.5	1.2	1.2	4.8	7.9	34.0	1.1	6.2	5.5	7.0	3.1	1.1	42.1	1.1	9.2	5.8	2.2	1.8	1.4	3.2	0.8	27.5	3.3	1.1	31.6	3.4	31.1	1.4	2.9	1.2	3.6	6.8	0.8	1.0	4.0	2.7	0.0	4.4	0.7	1.0	25.5	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	3.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.2	5.8	1.3	0.7	0.0	9.6	0.1	0.0	11.7	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.2	7.2	18.7	5.5	7.0	9.2	5.8	27.5	2.7
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428835-151440813	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 4.3;thyroid gland: 16.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;CAPAN-2: 2.6;MOLT-4: 2.0;SCLC-21H: 3.6"	"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"					"Group enriched"	"Detected in some"	31	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 3.4;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	35	"T-cells: 3.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 9.3"	"Not detected"	"Not detected"			HPA050788	Uncertain									"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.3	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.4	1.1	0.3			0.0	0.9	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0		0.4	0.0	2.6	0.8	0.3		0.3	0.0		0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0			16.3		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.6	0.0	0.3	0.0	0.7	1.0	2.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	2.0	0.5	1.1	0.6	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.4	2.2	0.0	0.0	0.0	0.0	0.0	0.4										
CSRP1	"CSRP, CYRP, D1S181E"	ENSG00000159176	"Cysteine and glycine rich protein 1"	P21291	1	201483530-201509456	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 338.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					25000000	25000000			"HPA045617: AB_2679391"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.58e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.96e-3)"	33.9	17.1	39.0	27.3	53.5	5.1	39.6	12.0	56.6	75.6	200.1	92.2	63.2	23.2	159.3	48.5	116.7	81.5	49.4	15.5	41.9	29.6	15.5	14.4	31.1	7.8	55.6	29.8	46.1	14.0	30.9	10.1	26.8	42.2	123.0	56.5	13.9	30.9	338.6	6.7	17.0	41.2	247.1	41.7	15.0	73.6	17.1	62.2	1.6	20.7	8.9	8.5	214.4	40.4	11.0	27.0	26.2	20.9	12.6	21.8	16.4	9.8	26.5	6.7	15.0	11.1	14.2	35.2	74.9	65.8	59.1	47.1	28.0	7.4	9.5	4.6	40.8	18.1	4.2	15.4	44.1	20.9	3.9	11.0	31.8	3.9	51.3	8.7	1.5	13.1	13.5	47.8	21.8	65.0	0.5	9.6	38.6	28.7	5.8	1.4	0.1	9.2	2.2	39.0	33.1	27.3	17.3	3.5	3.1	30.1	65.2	20.4	11.2	9.3	75.3	39.8	25.3	26.9	31.0	5.3	10.0	3.8	39.9	17.1	26.1	25.5	19.8	26.2	16.2	19.8	16.2	11.0	15.9	15.2	27.0	7.3	9.2	11.3	2.2	12.6	20.9	2.1	21.8	16.4	39.0	53.5	12.0	56.6	41.9	29.6	55.6	29.8	42.2	62.2
CWH43	"CWH43-C, FLJ21511"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986247-49062081	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.1;seminal vesicle: 22.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;NB-4: 1.4;SH-SY5Y: 1.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042814, HPA048140"	Uncertain									"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favourable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.1	0.0	0.1	9.3	0.1	0.0	1.0	0.1	0.2	5.1	9.7	0.2	11.1	0.0	2.0	2.2	19.8	8.6	0.4	0.1	0.1	0.1	7.6	1.1	0.8	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	26.1	9.1	0.4	2.7	22.9	0.1	16.9	0.1	1.9	0.1	0.1	5.2	0.7	0.1	0.3	10.6	12.6	3.6	3.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508493-15552317	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 44.6;skin 1: 29.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;MCF7: 5.2;RT4: 2.5;T-47d: 3.1;U-2 OS: 2.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 6.1;MAIT T-cell: 4.6;non-classical monocyte: 13.2"	"Group enriched"	"Detected in many"	9	"monocytes: 13.2;T-cells: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain									"HPA058960: AB_2683862"	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	0.5	0.0	0.0	0.1	0.0	0.1	3.6	0.0	0.0	5.4	0.1	0.0	10.3	0.2	0.6	0.2	12.1	0.1	0.6	0.0	0.0	0.0	0.0	19.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.2	0.0	0.0	1.6	44.6	1.2	29.0	0.1	1.0	0.0	0.3	0.5	0.7	0.0	0.4	0.0	14.7	6.7	5.5	10.3	0.0	0.2	0.0	13.2	1.0	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.8	6.1	4.6	0.0	0.6	1.5	0.2	0.0	0.0	0.4	0.0	1.0	13.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4"	"Cell line enriched"	"Detected in single"	77	"HDLM-2: 43.7"	"Group enriched"	"Detected in many"	6	"melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 37.2"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 37.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA046528	Uncertain									"HPA046528: AB_2679687"	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.0	11.4	3.4	3.9	4.2	0.7	1.0	1.6	8.0	0.9	1.0	1.1	25.1	2.1	1.3	1.7	0.7	3.4	1.6	11.5	4.1	3.4	1.8	1.0	1.5	4.4	3.3	1.5	5.4	0.5	0.7	2.3	22.6	3.7	3.4	1.1	2.9	0.7	22.4	0.5	1.3	2.5	0.7	2.3	6.9	1.1	1.0	2.9	1.0	1.1	0.5	1.5	1.0	1.2	0.0	0.9	37.2	3.2	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.0	37.2	0.2	3.2	0.0	0.0	0.4	0.0	0.9	0.0	0.5	0.1	0.1	0.4	2.0	0.0	0.3	0.4	3.4	4.2	1.6	8.0	4.1	3.4	3.3	1.5	3.7	2.9
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143166-96145440	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 151.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.3;HeLa: 13.9;Karpas-707: 17.4;NB-4: 14.4;RT4: 17.3;SCLC-21H: 15.5;U-698: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdTCR: 46.1"	"Group enriched"	"Detected in all"	10	"NK-cells: 29.6;T-cells: 46.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	6.4	3.1	2.0	13.1	4.3	51.3	2.9	1.3	4.3	4.8	3.9	1.9	7.9	0.8	4.3	18.3	4.1	3.0	8.8	7.4	3.0	1.4	5.5	3.4	15.9	19.0	1.8	0.8	3.0	1.7	0.4	14.6	0.6	2.0	10.7	1.1	2.8	2.0	151.1	1.8	9.8	4.7	3.7	1.6	16.4	2.1	3.3	0.7	43.4	2.4	2.6	12.2	24.6	14.1	3.9	2.3	1.4	2.2	29.6	46.1	7.5	1.5	0.0	0.1	0.1	0.2	0.3	2.2	1.9	0.0	2.8	2.7	4.4	0.3	15.3	5.5	2.1	1.1	3.8	0.0	0.5	0.2	0.0	0.3	13.9	0.0	1.0	6.3	1.3	0.5	1.0	0.4	0.0	0.0	0.0	17.4	0.1	2.6	12.4	14.4	3.4	5.4	0.0	0.2	12.1	0.1	17.3	15.5	0.8	0.7	0.2	2.8	1.0	7.2	0.0	0.0	4.1	0.0	0.8	1.2	1.8	21.0	0.0	6.9	0.1	0.5	0.9	0.2	46.1	2.2	22.6	3.9	11.4	41.4	2.3	2.6	7.8	23.9	1.4	29.6	1.8	0.6	3.4	7.5	2.0	4.3	1.3	4.3	3.0	1.4	1.8	0.8	2.0	0.7
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350668	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 30.0;SK-MEL-30: 46.2;WM-115: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	10.9	3.4	1.2	3.6	1.1	3.4	17.1	4.8	2.7	4.6	1.7	1.0	46.7	0.8	3.2	0.7	1.6	1.3	13.1	1.5	4.6	0.8	0.7	0.4	3.7	1.8	0.8	0.8	1.2	78.6	0.1	3.7	17.7	0.7	4.3	0.9	17.1	8.9	63.5	2.7	3.5	1.3	1.5	1.1	0.6	20.6	1.7	0.2	3.9	1.2	2.0	4.7	7.4	3.0	0.0	0.5	0.0	0.0	0.2	9.6	0.1	11.1	30.0	17.8	0.8	2.3	0.0	1.5	2.3	12.8	7.0	3.1	0.3	5.7	0.0	6.3	1.0	3.6	0.2	7.7	4.2	0.3	0.6	0.0	1.0	0.2	0.0	0.1	14.6	1.4	5.1	2.2	13.1	5.7	0.1	1.3	14.0	12.6	0.0	2.1	3.1	18.4	0.3	0.6	2.3	16.1	5.9	0.1	9.9	3.2	15.2	46.2	3.2	0.3	16.0	5.2	0.0	0.0	1.6	3.6	0.4	0.0	15.6	2.6	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	9.6	0.1	1.2	1.1	4.8	2.7	4.6	0.8	0.8	0.8	0.7	0.2
EDNRA		ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 62.6;seminal vesicle: 52.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.2;ASC TERT1: 14.2;HHSteC: 7.3;LHCN-M2: 16.8;SH-SY5Y: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Uncertain	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (1.50e-7)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	7.6	2.6	1.3	1.4	1.8	0.0	7.2	0.6	2.4	62.6	2.6	1.0	21.7	1.5	37.3	14.2	4.7	13.3	7.3	15.1	1.3	1.3	3.1	1.4	12.7	2.0	1.8	1.0	23.5	0.9	1.9	2.2	5.9	2.7	21.5	1.5	10.3	4.1	52.3	4.8	3.2	1.8	19.4	1.6	11.5	4.4	9.1	1.4	2.9	5.0	6.0	2.6	14.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.1	0.0	7.2	14.2	0.0	2.1	2.8	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.5	0.2	0.0	1.5	0.0	2.4	0.0	7.3	0.0	0.0	5.5	0.4	0.4	0.0	0.0	0.0	1.1	16.8	0.2	0.0	0.1	1.2	0.8	0.0	0.7	0.1	1.1	0.8	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.0	0.0	1.1	0.3	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.6	2.4	1.3	1.3	1.8	1.0	2.7	1.4
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34661057	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 34.7;HaCaT: 23.9;HBEC3-KT: 26.3;RT4: 53.1;T-47d: 53.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavourable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.8	1.0	0.8	9.3	0.9	0.0	32.1	0.7	0.7	19.3	16.0	0.5	152.4	6.9	4.5	21.4	69.0	23.0	22.1	0.7	0.9	0.9	11.6	1.6	9.9	0.1	1.5	0.3	4.7	10.5	0.2	0.9	0.5	1.4	20.7	22.3	0.2	118.0	161.8	0.7	12.8	10.1	1.7	3.3	0.7	10.1	1.4	0.5	0.4	1.2	50.3	59.7	13.7	30.3	0.0	4.9	0.0	0.4	0.0	0.0	0.2	11.4	6.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	34.7	0.0	4.4	0.0	23.9	0.0	26.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.2	4.7	53.1	0.0	0.0	0.1	3.6	0.0	53.8	0.1	0.0	0.0	0.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.7	0.7	0.9	0.9	1.5	0.3	1.4	0.5
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542444-117549546	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.8;epididymis: 53.9;seminal vesicle: 76.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 16.8;fHDF/TERT166: 18.6;RPTEC TERT1: 18.7;RT4: 5.9"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favourable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	4.6	0.5	11.5	0.6	10.3	0.5	1.4	0.5	12.5	23.5	0.7	7.3	46.8	0.5	40.5	53.9	0.7	25.4	1.2	0.6	14.7	2.1	25.5	0.5	0.5	0.7	1.8	10.4	5.7	0.5	0.6	1.1	0.6	2.5	1.9	0.5	3.4	1.3	76.3	5.1	4.7	0.5	22.6	0.6	0.5	0.5	3.6	6.2	0.0	0.5	1.2	0.7	4.2	2.4	0.7	0.5	2.4	0.9	1.0	0.7	0.1	0.0	0.0	0.0	1.8	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	16.8	18.6	0.1	0.4	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.1	18.7	5.9	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.6	0.5	0.6	0.7	0.4	0.4	0.4	0.4	0.7	0.6	0.5	1.1	1.0	0.9	0.5	0.6	0.1	11.5	10.3	0.5	12.5	14.7	2.1	1.8	10.4	2.5	6.2
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Group enriched"	"Detected in some"	18	"HEL: 5.0;Hep G2: 16.6;HMC-1: 7.4"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	480000	480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.0	0.0	16.6	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2
ETDC		ENSG00000283644	"Embryonic testis differentiation homolog C"		X	135309480-135309659	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 2.2;seminal vesicle: 2.9;skin 1: 3.9"	"Group enriched"	"Detected in some"	30	"HeLa: 3.6;SK-MEL-30: 3.6;U-937: 1.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		2.2	0.0		0.0	0.0	0.9			0.0	0.0	0.0	0.5	0.0	0.0	0.0			0.0	1.2	0.0	0.3			0.6	0.0	0.0		0.0		0.1	0.0		0.0	2.9	0.0	3.9	0.0	0.0		0.2	0.2	0.0			1.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9										
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9"	"Cell line enriched"	"Detected in some"	12	"RT4: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	26	"pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.0;pons and medulla: 1.0"	"Region enriched"	"Detected in single"	9	"pons and medulla: 1.1"	HPA055132			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.1	6.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.2	0.6	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	3.0	6.4	0.7	0.1	0.1	6.7	0.1	0.0	0.1	1.9	0.1	0.1	0.0	1.7	0.1	0.1	0.1	0.1	0.1	8.9	5.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.0	0.1
EVX2		ENSG00000174279	"Even-skipped homeobox 2"	Q03828	2	176077472-176083913	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.4;prostate: 3.8;seminal vesicle: 5.0;testis: 6.1;vagina: 2.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;SCLC-21H: 1.5;SH-SY5Y: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.6;pons and medulla: 1.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 0.8"	HPA041576	Uncertain									"HPA041576: AB_10796347"		"unprognostic (2.27e-1)"	"unprognostic (1.68e-3)"		"unprognostic (1.83e-1)"				"unprognostic (3.41e-1)"	"unprognostic (5.75e-1)"		"unprognostic (3.13e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.32e-1)"		"unprognostic (4.93e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.9			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		3.8	1.8		0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FADS2	"D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13"	ENSG00000134824	"Fatty acid desaturase 2"	O95864	11	61792980-61867354	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 204.5;seminal vesicle: 98.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 148.0;HBEC3-KT: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006741	Approved									"HPA006741: AB_1078796"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.21e-2)"	"unprognostic (8.95e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (1.00e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (3.42e-4)"	7.1	85.9	34.3	10.0	31.7	7.5	20.2	10.1	48.5	23.7	4.9	28.6	204.5	9.3	19.9	10.3	3.2	8.9	6.6	8.2	24.4	29.9	3.8	38.0	9.7	6.7	28.1	20.1	8.6	3.1	41.5	11.8	12.8	26.4	32.0	4.3	16.7	5.0	98.8	3.0	26.1	3.6	39.3	17.9	3.3	3.6	10.4	24.0	8.4	2.5	3.2	9.2	10.6	6.5	3.5	13.3	6.9	9.0	6.3	9.4	3.8	1.3	52.1	77.4	42.7	70.5	148.0	20.2	8.7	78.7	12.8	35.1	3.3	17.5	0.3	1.2	19.2	1.5	50.6	88.5	5.5	0.6	1.0	29.6	10.4	7.6	55.6	1.8	1.7	55.6	2.7	46.6	4.2	37.8	1.6	24.0	5.9	1.3	16.6	9.8	33.7	13.7	22.5	1.3	72.8	50.9	0.4	23.0	28.0	5.7	0.1	2.2	2.1	21.8	15.3	1.4	13.9	0.9	1.2	11.2	9.8	3.9	1.4	9.8	15.7	4.5	5.7	6.9	9.4	9.0	2.2	1.6	3.5	5.0	10.5	3.5	2.0	4.4	3.1	6.3	7.5	13.3	3.0	3.8	34.3	31.7	10.1	25.2	24.4	29.9	28.1	20.1	26.4	24.0
FAIM	"FAIM1, FLJ10582"	ENSG00000158234	"Fas apoptotic inhibitory molecule"	Q9NVQ4	3	138608606-138633376	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 61.9"	"Cell line enhanced"	"Detected in many"		"U-698: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042440, HPA052209"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA042440: AB_2677999, HPA052209: AB_2681761"	"unprognostic (6.45e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (3.96e-5)"	"unprognostic (4.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.63e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.98e-2)"	13.7	6.6	12.3	6.7	11.6	2.6	19.0	7.8	9.9	24.5	6.8	10.2	38.5	4.7	9.6	15.1	8.8	28.5	9.0	4.7	12.2	12.5	15.4	6.0	7.6	7.2	13.9	7.1	8.4	27.5	7.2	15.4	6.1	10.7	11.4	6.0	9.1	7.2	61.9	6.1	6.2	4.2	7.2	19.6	3.7	6.7	5.4	9.1	13.2	15.2	9.3	9.6	10.3	13.2	13.9	5.0	11.1	2.6	13.9	9.1	3.4	26.5	5.2	0.5	4.7	5.1	9.6	19.1	8.2	5.0	8.7	7.5	8.9	7.8	0.0	7.3	10.7	7.0	22.7	4.7	9.8	21.8	23.7	5.0	14.4	12.9	5.7	0.0	1.6	13.5	9.1	3.2	5.0	9.4	3.2	6.8	5.4	10.1	0.1	22.5	10.3	5.2	26.8	6.2	0.7	13.8	13.2	9.0	7.6	14.6	8.1	20.5	13.7	6.6	5.7	1.8	4.1	8.9	3.9	0.0	0.1	44.7	7.2	0.0	7.1	11.1	2.4	1.7	9.1	2.6	8.5	13.9	5.0	7.2	5.0	7.9	3.4	8.5	0.3	13.9	1.7	3.5	5.4	3.4	12.3	11.6	7.8	8.2	12.2	12.5	13.9	7.1	10.7	9.1
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69505241-69532508	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.8;HAP1: 15.2;Hep G2: 5.5;NTERA-2: 21.0;SCLC-21H: 10.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain									"HPA036093: AB_10673613"	"prognostic unfavourable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavourable (1.83e-4)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.0	0.5	1.4	0.0	1.1	0.0	0.1	3.5	1.4	0.1	0.0			0.0	0.2	0.3	0.0	0.7	0.1	25.0	1.1	2.1	0.5	0.0	0.0	0.0	1.3		0.0	1.8	0.9	1.1	0.0		0.9	0.0		1.1	6.7	0.0	0.0	0.0	0.0	0.4	0.6	0.5	0.8			10.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.6	0.0	4.2	0.0	0.0	15.2	0.6	0.0	0.0	4.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.7	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	0.7	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM3D	"EF7, OIT1"	ENSG00000198643	"Family with sequence similarity 3 member D"	Q96BQ1	3	58633946-58666848	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.4;RT4: 2.8;T-47d: 2.3;U-266/70: 1.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013844	Approved				"Secreted to digestive system"	8200	8200			"HPA013844: AB_2668897"	"prognostic favourable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.3	0.2	0.3	8.5	0.3	0.0	2.2	0.2	0.2	4.4	48.2	0.3	26.1	11.2	0.5	0.3	61.2	0.3	20.0	0.2	0.2	0.2	0.5	0.2	1.5	0.2	0.3	0.2	0.2	0.8	0.0	0.3	0.5	0.3	3.3	69.2	0.3	146.0	88.6	0.4	0.8	26.1	0.8	0.2	0.3	9.5	0.3	0.2	0.3	0.6	15.2	47.1	2.2	13.1	0.0	0.7	6.7	1.6	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	3.4	0.3	0.0	0.0	1.3	0.3	1.4	0.7	0.0	0.3	0.5	1.0	0.1	2.8	0.2	1.3	0.0	0.0	0.0	2.3	0.0	0.5	0.1	0.7	0.9	0.6	1.8	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.5	0.0	0.0	0.9	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994949-40043529	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.4;seminal vesicle: 33.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 22.8;hTERT-HME1: 7.2;RT4: 10.9;SCLC-21H: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favourable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favourable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.1	0.2	0.1	2.8	0.2	0.8	4.7	0.2	0.3	2.6	6.9	0.1	29.4	3.0	0.2	7.5	15.4	1.1	4.0	1.5	0.2	0.1	4.8	2.1	1.0	0.1	0.2	0.1	0.5	14.4	2.6	2.6	0.5	0.1	6.3	3.1	0.4	7.8	33.3	0.1	13.8	12.5	0.8	0.2	0.1	5.9	24.9	0.1	1.3	12.6	12.8	8.1	3.0	4.1	0.7	0.5	2.7	0.4	0.6	0.3	0.1	4.7	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	7.0	1.4	0.0	0.0	0.0	7.6	0.0	9.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	22.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	10.9	24.1	0.0	0.2	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.3	2.2	0.6	0.3	0.5	0.1	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.1
FAT3	"CDHF15, CDHR10, KIAA1989"	ENSG00000165323	"FAT atypical cadherin 3"	Q8TDW7	11	92352096-92896470	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;seminal vesicle: 6.0"	"Cell line enhanced"	"Detected in some"		"AF22: 8.0;fHDF/TERT166: 2.4;NTERA-2: 2.7;U-2 OS: 2.3;U-251 MG: 4.6"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026878	Uncertain									"HPA026878: AB_1848430"	"unprognostic (5.00e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.76e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.66e-4)"	"unprognostic (8.83e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.25e-1)"	0.5	0.1	2.6	0.1	10.5	0.1	0.3	1.4	7.3	0.4	0.2			0.1	0.4	1.0	0.1	0.4	0.2	0.2	1.8	2.2	0.4	0.1	1.4	0.0	2.2		0.8	0.0	0.0	1.8	0.2		3.2	0.2		0.1	6.0	0.2	0.1	0.1	0.2	0.2	0.2	1.2	0.8			0.0		0.4	1.3	0.3	0.2	0.2	0.7	0.0	0.2	0.3	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.0	1.6	2.4	1.3	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.2	0.3	0.0										
FDX1	"ADX, FDX"	ENSG00000137714	"Ferredoxin 1"	P10109	11	110429883-110464881	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.9;seminal vesicle: 55.6"	"Cell line enhanced"	"Detected in all"		"U-698: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041630, HPA062087"	Enhanced		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA041630: AB_10793970, HPA062087: AB_2630366"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.48e-2)"	"prognostic favourable (3.58e-7)"	"prognostic favourable (2.53e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.80e-1)"	5.5	113.9	3.9	4.7	4.5	3.9	5.6	2.7	4.0	3.2	7.5	5.2	33.7	7.9	3.2	3.9	5.1	3.0	5.6	9.6	3.6	4.3	10.7	22.8	7.8	4.7	4.5	2.5	3.5	8.6	3.5	3.7	48.4	3.1	4.8	4.2	4.2	4.1	55.6	7.3	3.3	12.3	3.6	3.4	3.9	5.0	5.3	2.6	5.2	8.7	5.0	3.5	5.6	5.4	10.7	6.9	3.4	5.8	4.4	8.7	2.9	5.2	3.7	5.7	6.2	5.6	10.0	12.8	4.9	6.0	4.3	7.4	12.6	8.9	12.4	14.4	6.3	6.3	6.6	7.4	5.9	11.8	8.4	6.2	6.5	7.7	9.8	6.5	10.2	17.3	6.1	3.9	9.3	8.8	6.2	18.5	9.2	5.8	9.2	14.6	5.1	7.0	13.7	5.4	11.4	9.4	9.5	7.8	4.0	9.3	10.6	6.2	6.2	4.5	5.2	4.4	5.4	5.3	5.2	4.2	3.2	37.2	3.3	13.4	5.6	1.8	5.7	3.4	5.3	4.2	5.8	10.7	7.3	7.4	6.9	7.5	8.6	6.1	0.7	4.4	5.8	5.3	8.7	2.9	3.9	4.5	2.7	4.0	3.6	4.3	4.5	2.5	3.1	2.6
FGF16	MF4	ENSG00000196468	"Fibroblast growth factor 16"	O43320	X	77447405-77457278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.2;seminal vesicle: 4.2"	"Cell line enriched"	"Detected in some"	5	"U-2197: 22.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 1.5;hypothalamus: 1.1;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 3.7;hippocampal formation: 2.2;olfactory region: 8.3"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (4.01e-2)"					"unprognostic (5.30e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"			"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.49e-2)"		3.2	0.0	0.2	0.1	0.2	0.0	2.3	0.1	1.5	0.1	0.5	0.7	0.1	0.0	1.2	0.6	0.5	0.4	0.7	1.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	1.8	0.1	0.2	0.1	0.5	4.2	1.3	0.4	0.4	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	2.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.5	0.1	1.1	0.1	0.1	1.8	0.1
FHOD3	"FHOS2, FLJ22297, FLJ22717, KIAA1695"	ENSG00000134775	"Formin homology 2 domain containing 3"	Q2V2M9	18	36297714-36780055	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 70.0;seminal vesicle: 33.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.6;HDLM-2: 31.7;SH-SY5Y: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021827, HPA024696"	Uncertain				"Intracellular and membrane"					"HPA021827: AB_1848571, HPA024696: AB_1848573"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.11e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-2)"	"prognostic favourable (1.19e-5)"	"unprognostic (1.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.20e-1)"	2.0	13.2	11.4	1.5	6.3	0.4	6.2	2.1	10.9	2.8	5.6	3.2	5.6	1.2	1.9	22.0	5.1	6.0	3.9	70.0	9.5	6.7	10.7	0.8	1.1	0.9	6.0	8.5	4.6	1.4	0.5	4.4	1.0	20.1	14.1	2.1	6.6	6.1	33.3	23.3	3.1	2.4	5.1	4.8	1.0	1.6	2.8	1.8	0.0	2.2	1.7	2.2	6.3	3.3	0.0	0.6	0.0	0.1	0.0	0.6	0.0	6.1	2.2	14.2	3.3	0.1	0.0	1.0	13.8	29.6	2.8	2.7	0.0	10.0	1.1	3.7	6.6	7.9	4.7	6.0	1.6	31.7	1.6	0.0	0.4	0.0	0.1	0.0	0.4	1.9	2.9	1.5	0.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	3.1	2.0	0.0	0.0	7.5	13.4	6.8	7.9	18.6	3.0	0.0	1.9	0.0	0.0	16.0	8.9	0.7	0.4	11.7	13.2	0.0	0.0	10.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	11.4	6.3	2.1	10.9	9.5	6.7	6.0	8.5	20.1	1.8
FIBIN	MGC24932	ENSG00000176971	"Fin bud initiation factor homolog (zebrafish)"	Q8TAL6	11	26994184-26996121	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 58.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 32.0;ASC TERT1: 20.4;HHSteC: 41.5;HSkMC: 43.0;hTCEpi: 11.2"	"Cancer enhanced"	"Detected in all"		"glioma: 48.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040120	Uncertain				"Intracellular and membrane"					"HPA040120: AB_10795243"	"unprognostic (1.72e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (1.93e-5)"	"prognostic unfavourable (6.72e-4)"	"unprognostic (8.48e-2)"	"prognostic unfavourable (1.85e-6)"	"unprognostic (1.02e-2)"	17.1	4.9	7.5	6.7	6.2	0.3	14.9	2.1	12.0	22.4	11.0	8.4	3.3	2.3	11.6	8.7	17.9	13.2	7.4	17.2	8.2	3.8	11.7	1.9	15.6	2.6	8.3	6.1	15.7	3.7	0.4	1.1	11.7	8.0	16.8	2.8	16.5	8.4	58.9	10.5	7.6	5.0	15.6	7.9	12.0	9.9	5.0	5.5	0.3	12.6	7.6	1.9	9.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	32.0	20.4	0.0	1.0	2.6	0.1	0.4	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	41.5	0.0	0.0	43.0	11.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	6.2	2.1	6.4	8.2	3.8	8.3	6.1	8.0	5.5
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.2;ductus deferens: 85.8;seminal vesicle: 209.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 55.8;HEL: 68.8;HMC-1: 37.2;SH-SY5Y: 65.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 36.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	339	"basophil: 81.2"	"Lineage enriched"	"Detected in single"	813	"granulocytes: 81.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favourable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (5.22e-5)"	7.0	6.2	2.1	1.5	2.4	2.5	7.9	1.2	1.9	22.4	2.8	1.4	85.8	2.5	20.6	5.4	3.2	23.0	9.7	4.8	1.5	1.0	7.6	0.6	16.1	2.2	1.8	1.1	4.6	5.8	3.4	4.5	51.8	2.4	27.8	1.8	6.1	1.9	209.1	3.5	4.1	3.4	8.4	1.4	5.1	2.9	2.7	1.5	0.4	3.3	2.7	1.5	22.4	12.4	0.0	0.0	81.2	0.0	0.0	0.0	0.4	4.6	1.1	0.2	3.1	0.4	0.1	55.8	10.4	8.9	3.6	1.3	1.9	2.0	0.1	2.9	6.1	4.9	2.9	0.0	1.5	0.0	1.6	68.8	7.6	3.0	0.8	6.9	37.2	0.0	0.0	0.1	0.0	5.6	18.0	0.1	0.0	1.7	0.0	14.1	0.2	0.3	0.0	1.3	0.0	0.1	4.1	4.3	65.0	2.6	13.8	0.4	2.6	2.8	10.0	0.2	0.1	2.5	1.4	0.0	0.0	0.0	0.1	0.4	0.7	81.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	2.4	1.2	1.9	1.5	1.0	1.8	1.1	2.4	1.5
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 97.8;skin 1: 61.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 32.6;MCF7: 77.8;RT4: 31.8;SH-SY5Y: 27.3;T-47d: 101.3"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	42	"gdTCR: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9"	"Group enriched"	"Detected in many"	54	"NK-cells: 16.6;T-cells: 18.9"	"Region enriched"	"Detected in single"	6	"midbrain: 7.3"	"Group enriched"	"Detected in some"	46	"midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB016217: AB_2108591, HPA029730: "	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	2.0	2.0	0.3	3.4	0.3	0.9	17.8	0.3	0.3	1.8	0.5	0.1	44.4	0.1	0.4	13.5	0.8	0.4	0.4	0.9	0.3	0.4	12.9	0.7	1.6	2.7	0.8	0.0	0.3	0.4	55.0	3.8	53.4	1.4	8.1	0.0	1.8	8.9	97.8	0.8	61.7	1.2	3.4	0.4	2.7	0.5	0.8	0.1	42.4	3.3	0.6	3.4	26.9	16.4	0.2	0.0	0.3	0.0	16.6	18.9	3.0	5.4	1.3	0.0	0.0	0.0	0.0	32.6	0.1	0.0	0.0	0.0	2.0	4.9	0.0	0.0	0.0	4.7	0.5	0.1	0.0	15.6	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.3	2.5	0.0	0.0	0.0	77.8	8.5	0.0	0.5	0.7	0.4	0.4	0.1	0.0	31.8	1.6	27.3	0.0	4.4	0.0	101.3	0.0	0.0	0.4	1.0	0.2	0.6	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	9.7	0.0	13.3	0.2	18.2	14.1	0.0	0.0	10.0	9.0	0.3	16.6	0.0	0.0	18.9	3.0	0.3	0.3	0.3	0.3	0.3	0.4	0.8	0.0	1.4	0.1
GDF7	BMP12	ENSG00000143869	"Growth differentiation factor 7"	Q7Z4P5	2	20666664-20679245	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 13.3;seminal vesicle: 22.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.5;Hep G2: 6.2;RT4: 11.9;SH-SY5Y: 4.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.6;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	8	"B-cells: 2.6"	"Region enhanced"	"Detected in single"		"amygdala: 0.3"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (1.35e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.10e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.63e-3)"	"unprognostic (6.31e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.02e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-3)"	0.3	0.3	0.4	1.5	0.5	0.0	0.2	0.5	1.3	13.3	0.4	0.2	4.7	0.0	6.8	3.1	0.9	0.6	1.8	2.4	0.2	0.2	3.3	7.2	0.5	3.1	2.9	0.9	0.4	0.8	0.0	0.6	2.3	0.4	3.6	0.0	2.4	1.1	22.0	0.6	1.5	1.5	1.0	0.2	3.2	0.7	0.7	1.2	0.2	0.2	0.0	1.5	1.6	6.0	2.6	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	1.8	11.9	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.5	0.5	1.3	0.2	0.2	2.9	0.9	0.4	1.2
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.8;Karpas-707: 52.7;RPMI-8226: 51.8;RPTEC TERT1: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA045635, HPA047534, HPA065444"	Supported		Approved	Vesicles	"Intracellular and membrane"	4600000	4600000	Vesicles	Vesicles	"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favourable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favourable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.4	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.3	0.2	4.3	0.0	2.8	1.4	0.2	0.1	35.8	2.9	0.1	8.6	14.1	1.5	0.3	12.0	0.4	0.2	0.6	0.4	0.1	2.0	52.7	0.2	0.4	0.3	14.6	1.4	0.2	0.2	2.2	51.8	48.2	0.6	0.2	0.3	0.1	9.4	0.2	9.4	11.1	2.2	3.5	2.3	10.9	0.3	15.8	6.0	0.2	7.4	15.1	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1
GLB1L3	FLJ90231	ENSG00000166105	"Galactosidase beta 1 like 3"	Q8NCI6	11	134274245-134319564	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;prostate: 18.5;seminal vesicle: 10.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.8;HEK 293: 8.0;MOLT-4: 2.9;NTERA-2: 4.9;PC-3: 6.6;SCLC-21H: 10.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdTCR: 2.3;memory CD4 T-cell: 5.7;memory CD8 T-cell: 3.5;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	57	"T-cells: 5.7"	"Not detected"	"Not detected"							HPA039916	Uncertain									"HPA039916: AB_2676746"	"unprognostic (1.64e-3)"	"unprognostic (7.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (8.69e-3)"	"prognostic favourable (1.97e-4)"	"unprognostic (6.58e-3)"	"unprognostic (3.81e-1)"	"unprognostic (6.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.52e-5)"	"unprognostic (1.39e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.07e-1)"	0.5	2.7	4.0	1.2	19.1	0.6	1.2	10.3	14.4	0.8	1.2	0.0	0.0	0.5	3.8	0.4	0.5	0.4	0.5	0.4	2.7	2.6	1.3	0.4	0.5	2.1	1.4	6.1	0.4	0.6	0.4	1.1	0.5	5.8	18.5	0.5	1.0	3.4	10.8	0.5	5.4	0.5	0.5	0.6	0.6	0.6	2.4	1.4	0.0	3.4	0.0	0.8	0.9	1.2	0.0	0.0	0.0	0.0	0.0	5.7	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.3	0.0	2.8	8.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	4.9	6.6	0.0	0.0	0.0	0.0	0.0	10.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	5.7	3.5	0.0	0.0	4.8	3.6	0.0	0.0	0.0	0.0	2.4	1.0	4.0	19.1	10.3	14.4	2.7	2.6	1.4	6.1	5.8	1.4
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.9;seminal vesicle: 14.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;BJ hTERT+: 6.2;PC-3: 9.9;U-138 MG: 7.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001409	Uncertain									"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.1	0.1	0.5	0.6	1.2	0.0	0.9	3.9	1.6	4.2	0.5	0.5	0.5	0.6	1.4	1.0	0.6	0.8	1.0	1.0	2.3	0.7	3.3	0.5	0.5	0.5	0.5	0.5	1.0	0.5	0.0	0.5	1.2	0.8	8.9	0.1	5.5	0.5	14.7	0.5	1.7	0.6	0.5	0.5	0.5	0.9	4.1	0.5	0.5	0.5	0.5	1.0	2.7	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	4.0	5.2	0.0	2.7	6.2	2.4	1.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.8	0.0	1.7	0.0	1.8	0.1	1.4	0.0	0.0	3.6	0.2	3.0	2.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	9.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	1.3	0.1	1.8	0.0	0.0	4.4	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	3.9	1.6	2.3	0.7	0.5	0.5	0.8	0.5
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 57.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.2;HSkMC: 23.0;RPTEC TERT1: 14.3;U-251 MG: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	5.6	2.8	5.6	4.4	7.4	1.0	2.9	3.5	9.5	13.4	2.9	10.7	33.5	1.6	6.1	6.5	1.5	15.0	14.7	4.7	8.9	4.5	11.4	5.1	5.7	2.6	7.7	3.8	10.4	17.3	6.4	8.8	2.8	16.3	5.3	4.0	4.6	5.2	57.8	2.1	1.4	2.2	5.1	26.7	3.8	3.2	4.6	10.2	0.0	29.3	1.4	1.7	5.6	8.8	0.0	0.0	1.8	0.9	0.3	0.7	0.0	0.6	6.6	2.0	0.0	2.6	7.3	0.2	5.0	15.2	2.2	3.3	1.1	2.4	0.0	4.0	3.7	0.0	1.3	0.0	4.7	1.5	1.0	0.0	0.3	0.0	8.0	0.7	0.0	23.0	0.0	7.0	0.7	0.4	0.0	0.1	1.9	0.2	0.0	0.9	0.1	0.9	0.0	4.6	0.0	14.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.0	2.6	0.6	2.6	11.9	0.0	0.0	0.0	7.0	0.0	2.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.7	1.1	0.3	0.9	0.0	0.1	0.0	5.6	7.4	3.5	9.5	8.9	4.5	7.7	3.8	16.3	10.2
GPR158	KIAA1136	ENSG00000151025	"G protein-coupled receptor 158"	Q5T848	10	25175062-25602226	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;seminal vesicle: 11.2"	"Group enriched"	"Detected in some"	5	"HEL: 20.7;T-47d: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013185	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA013185: AB_2113957"	"unprognostic (4.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.66e-5)"	"unprognostic (5.67e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.60e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (3.90e-1)"	0.9	2.4	3.6	1.0	16.2	0.8	0.8	28.4	25.2	0.8	1.1	1.6	6.1	0.9	0.8	1.0	0.8	0.8	0.8	0.8	1.9	2.8	0.8	0.9	0.9	0.8	2.4	4.8	0.8	0.9	1.5	8.9	1.5	14.9	1.2	1.1	1.4	0.8	11.2	0.8	0.8	1.2	0.8	4.0	0.9	1.1	1.9	2.9	0.0	1.0	0.0	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	20.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.5	1.1	1.9	5.7	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	16.2	28.4	11.6	1.9	2.8	2.4	4.8	14.9	2.9
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492432-101669726	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 47.9;seminal vesicle: 42.4"	"Cell line enhanced"	"Detected in some"		"A-431: 15.5;CACO-2: 11.3;HaCaT: 18.9;hTCEpi: 14.8;MCF7: 13.0;RT4: 27.9;T-47d: 32.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavourable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.4	0.3	0.4	3.3	0.4	0.0	11.3	0.3	0.4	6.0	9.9	0.0	34.7	2.1	1.6	16.4	18.7	5.2	10.3	0.4	0.4	0.4	6.4	0.7	11.3	0.0	0.4	0.0	1.5	22.1	7.1	1.5	47.9	0.1	15.2	5.6	0.1	15.0	42.4	0.4	18.0	8.6	1.6	0.4	0.4	5.9	0.6	0.0	1.7	12.7	14.3	12.2	7.4	8.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	15.5	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	11.3	7.7	0.0	0.0	0.0	18.9	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.5	0.0	0.0	6.2	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.0	0.1	0.0
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell line enhanced"	"Detected in some"		"HEL: 26.6;HeLa: 31.8;HHSteC: 25.4;hTEC/SVTERT24-B: 23.0;HUVEC TERT2: 19.5;MOLT-4: 34.3"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	Cytosol				Cytosol	Cytosol	"CAB022669: , CAB047357: , HPA048652: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.7	0.4	0.0	0.1	0.2	0.0	0.1	26.6	31.8	0.5	25.4	0.0	0.2	0.0	0.0	23.0	0.1	19.5	0.0	17.8	0.7	0.0	34.3	0.2	17.1	0.0	0.1	0.1	3.3	2.8	0.0	1.6	0.2	0.0	0.1	0.1	0.3	14.0	0.0	11.4	0.6	0.2	0.0	14.3	18.8	1.1	9.8	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 115.3;testis: 96.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 44.8;T-47d: 94.8;WM-115: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.1;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Supported	Cytosol		560000	560000	Cytosol	Cytosol	"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: "	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	7.5	11.3	21.4	2.9	27.8	0.9	23.1	8.5	18.4	15.4	11.7	9.9	51.0	12.6	9.0	67.2	11.1	8.8	12.3	27.6	14.0	14.4	54.0	5.3	5.2	2.4	9.6	22.0	32.3	26.5	7.3	9.4	5.8	30.7	13.6	5.6	13.4	4.5	115.3	15.5	15.0	7.5	15.9	13.3	3.3	14.2	96.0	6.4	0.1	15.8	15.6	3.3	17.4	12.0	0.6	0.8	4.1	0.3	1.0	11.1	1.4	0.0	1.3	9.7	0.0	13.2	8.1	1.6	10.5	1.8	11.5	11.2	4.2	0.3	0.0	6.1	5.3	0.5	1.9	4.3	16.0	0.0	2.9	9.8	31.8	6.3	14.1	0.0	22.8	8.1	5.3	17.3	0.0	14.2	0.8	0.1	5.1	5.7	2.6	0.2	1.0	18.2	0.0	6.2	0.4	3.2	22.5	17.1	9.2	21.9	44.8	2.0	94.8	14.3	11.1	0.1	4.2	11.8	6.9	1.5	2.4	0.0	0.1	0.0	36.8	0.8	0.3	4.1	4.2	0.1	1.2	0.6	5.3	3.1	0.1	0.6	11.1	5.5	2.0	1.0	0.2	0.8	2.3	1.4	21.4	27.8	8.5	18.4	14.0	14.4	9.6	22.0	30.7	6.4
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.2;EFO-21: 17.7;HEK 293: 21.4;RPTEC TERT1: 16.6;U-251 MG: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	40	"pons and medulla: 9.3"	"Region enriched"	"Detected in single"	29	"pons and medulla: 12.9"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (8.45e-6)"	8.3	4.5	1.0	7.3	1.1	0.2	8.0	1.0	1.0	11.3	16.4	1.0	56.7	2.3	10.1	44.9	5.5	17.7	3.6	1.7	1.0	0.0	16.3	1.6	4.8	1.6	1.0	1.0	2.8	1.7	6.7	1.0	3.8	2.6	4.1	4.9	1.0	1.0	68.4	4.0	2.9	11.3	3.5	4.8	6.5	7.8	3.7	1.0	1.0	1.8	1.0	1.1	6.4	5.2	0.1	2.8	1.7	0.9	1.4	1.1	0.4	3.2	6.8	4.6	2.1	3.8	5.4	1.2	0.1	0.0	0.1	0.1	3.2	20.2	1.6	17.7	14.5	0.1	0.9	0.3	0.0	5.2	21.4	5.0	3.0	0.0	6.3	0.0	13.3	6.2	0.0	6.0	0.4	6.3	6.8	0.1	3.7	0.1	0.3	0.1	0.1	0.7	0.0	3.3	0.6	16.6	3.0	0.0	0.0	0.7	0.0	3.3	6.5	1.4	7.0	2.2	7.0	1.2	19.1	1.7	2.0	0.1	4.5	0.0	3.7	1.7	0.1	0.0	0.9	0.1	0.4	0.0	0.5	1.1	0.3	0.1	0.8	1.0	0.0	1.4	0.9	2.8	1.1	0.4	1.0	1.1	1.0	1.0	1.0	0.0	1.0	1.0	2.6	1.0
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593961	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 21.1;RPTEC TERT1: 15.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enriched"	"Detected in single"	33	"pons and medulla: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	90	"pons and medulla: 24.0"	"Region enriched"	"Detected in single"	100	"pons and medulla: 14.7"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favourable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favourable (8.59e-5)"	3.4	3.1	0.2	2.1	0.2	0.0	5.0	0.2	0.7	5.4	10.5	0.2	25.9	1.5	2.2	18.5	0.6	7.2	0.2	0.7	0.2	0.0	16.0	0.4	5.2	0.8	0.2	0.2	1.9	0.5	0.9	0.2	1.2	25.4	1.3	4.7	0.2	0.6	27.6	0.2	0.5	9.5	1.6	22.5	2.0	4.3	0.7	0.2	0.2	0.7	0.2	0.2	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.7	0.0	2.4	2.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.1	2.6	0.0	0.2	0.0	0.0	0.0	21.1	0.9	5.4	0.0	4.1	0.0	1.2	1.3	0.0	2.8	0.0	1.4	1.6	0.0	3.2	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	15.7	1.6	0.0	0.0	0.1	0.0	2.3	0.4	0.0	5.2	0.7	2.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	25.4	0.2
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 73.7;seminal vesicle: 56.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 13.1;HEK 293: 36.2;RPTEC TERT1: 24.6;TIME: 13.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.5"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.0"	"Region enriched"	"Detected in single"	60	"pons and medulla: 10.6"	"Region enriched"	"Detected in single"	62	"pons and medulla: 14.6"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA042063: "	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	5.2	4.3	0.3	18.1	0.3	0.0	3.8	0.3	0.3	12.0	8.5	0.3	73.7	0.5	7.2	30.5	0.4	8.7	0.3	0.3	0.3	0.0	26.6	0.4	3.4	0.3	0.3	0.3	0.6	0.6	1.9	0.3	1.5	0.9	4.3	3.8	0.3	0.3	56.7	1.0	0.6	8.2	1.8	10.0	1.7	5.9	1.8	0.3	0.3	0.3	0.3	0.3	4.2	10.0	1.5	0.2	0.0	0.0	0.0	1.0	0.3	2.3	5.4	0.0	2.8	2.5	2.7	0.0	0.0	0.0	0.0	0.0	2.9	3.5	0.0	13.1	6.4	0.0	0.6	0.2	0.0	0.1	36.2	3.2	9.0	0.0	3.8	0.2	8.4	3.2	0.1	5.2	0.1	2.4	2.0	0.0	7.2	0.1	0.0	0.1	0.0	2.1	0.0	6.1	0.3	24.6	1.1	0.0	0.0	1.9	0.0	3.5	0.9	1.1	13.6	0.5	2.8	2.2	10.0	0.0	0.0	0.0	0.4	0.0	4.4	0.0	0.0	0.0	0.7	0.0	0.2	1.4	0.4	1.0	0.2	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.9	0.3
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188579-176190907	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.7;Hep G2: 5.9;RPTEC TERT1: 18.3;RT4: 14.1;SCLC-21H: 4.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040062: AB_2676826, HPA056900: AB_2683270"	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.4	0.6	1.5	1.1	3.5	0.3	2.0	0.6	3.9	0.5	5.2	18.8	11.8	0.7	0.8	14.1	0.9	8.8	1.4	0.3	4.1	2.2	6.8	0.2	5.7	0.9	9.8	1.3	1.2	0.5	0.2	0.2	0.3	15.5	1.7	3.7	0.3	1.0	20.4	0.3	1.2	4.4	0.9	18.9	1.5	0.7	2.2	6.3	0.0	0.4	0.0	0.5	4.6	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	18.3	14.1	4.9	0.8	0.0	0.0	0.9	0.0	0.0	3.3	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.5	0.6	3.2	4.1	2.2	9.8	1.3	15.5	6.3
HOXD12	HOX4H	ENSG00000170178	"Homeobox D12"	P35452	2	176099730-176101193	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.5;seminal vesicle: 4.8;vagina: 3.7"	"Group enriched"	"Detected in some"	4	"REH: 7.1;SCLC-21H: 2.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	41	"basal ganglia: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059444	Uncertain									"HPA059444: AB_2684020"		"unprognostic (1.00e-1)"	"unprognostic (2.40e-3)"		"unprognostic (1.32e-2)"	"unprognostic (3.53e-2)"		"unprognostic (1.71e-2)"	"unprognostic (1.36e-2)"			"unprognostic (7.11e-2)"		"unprognostic (4.54e-2)"	"unprognostic (7.29e-2)"		"unprognostic (1.44e-2)"	0.1	0.0	0.1	0.1	4.3	0.0	0.1	0.1	0.1	1.4	3.5	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.8	3.4	0.1	0.1	4.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.1	0.2	1.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	1.1	0.5	0.1	7.1	0.0	0.0	0.0	0.1	2.0	0.2	0.6	0.0	0.9	0.9	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HOXD13	"HOX4I, SPD"	ENSG00000128714	"Homeobox D13"	P35453	2	176092891-176095938	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0"	"Group enriched"	"Detected in some"	4	"HAP1: 9.6;HEK 293: 27.6;HL-60: 30.7;NB-4: 18.3;SCLC-21H: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064064			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064064: AB_2685186"	"unprognostic (2.04e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.95e-5)"	"unprognostic (2.52e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.08e-2)"		"unprognostic (4.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.66e-1)"		"unprognostic (1.01e-2)"	"unprognostic (2.82e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.70e-2)"		"unprognostic (9.98e-3)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	14.0	13.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	13.8	8.8	0.1	0.1	19.0	0.6	0.0	0.1	3.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	3.8	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	1.5	0.0	27.6	4.2	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	18.3	0.9	1.5	0.0	0.1	0.0	0.0	0.2	8.0	1.9	1.9	0.0	4.4	0.0	0.0	0.0	1.0	0.0	0.4	2.5	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 7.9;HSkMC: 9.3;RPTEC TERT1: 9.7;SCLC-21H: 13.8;SH-SY5Y: 9.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"pons and medulla: 3.8"	"Region enriched"	"Detected in single"	30	"pons and medulla: 6.7"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	6.2	1.1	0.4	3.2	0.4	0.2	19.6	0.2	0.2	8.7	3.6	0.0	22.5	0.3	25.9	36.4	1.1	4.8	2.0	0.4	0.8	0.5	8.5	0.2	0.3	0.8	1.5	0.0	7.0	0.3	0.2	0.2	0.2	0.5	2.1	0.4	0.0	0.6	22.6	0.7	0.7	0.4	4.0	7.2	1.9	0.3	3.6	0.0	0.0	0.4	0.2	0.3	1.7	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	9.3	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	9.7	0.5	13.8	9.3	0.1	0.1	3.9	0.0	0.0	0.6	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.8	0.5	1.5	0.0	0.5	0.0
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.1;HEK 293: 21.6;RPTEC TERT1: 16.0;SK-MEL-30: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	31	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.7	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.1	1.6	0.1	1.5	0.0	0.2	0.0	21.6	0.2	0.0	0.0	0.3	0.0	0.0	4.9	1.4	0.0	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	16.0	2.5	1.3	2.1	0.3	0.0	6.0	0.0	0.0	2.7	0.2	0.1	1.4	1.1	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 4.9;RT4: 9.0;SCLC-21H: 17.5;U-266/70: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved									"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.5	1.9	3.3	0.9	13.1	1.3	0.5	0.6	11.9	0.8	1.0	9.1	3.5	0.7	0.8	0.5	0.6	0.6	0.7	0.5	4.2	3.5	0.9	0.5	1.1	0.5	6.1	2.7	0.6	1.3	0.5	0.3	0.6	7.8	0.7	0.9	0.6	0.7	9.4	10.1	1.3	1.2	0.9	7.5	0.5	1.2	0.9	8.0	0.0	0.6	0.0	0.5	2.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	4.9	0.0	1.0	0.0	0.0	9.0	17.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	4.4	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.3	13.1	0.6	5.7	4.2	3.5	6.1	2.7	7.8	8.0
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43451003-43453989	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 130.4;seminal vesicle: 80.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 38.7;WM-115: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA040092	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA040092: AB_10795374"	"prognostic favourable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favourable (2.72e-5)"	16.5	12.5	11.6	12.1	10.1	5.3	12.8	11.3	9.7	14.6	16.5	13.0	130.4	23.4	15.8	14.8	8.4	15.3	16.7	10.9	9.2	10.0	15.9	25.8	17.8	6.7	10.9	9.3	25.1	34.0	13.8	11.2	10.8	9.0	15.6	7.5	15.0	20.8	80.0	8.8	8.4	22.1	13.4	14.3	7.6	14.1	4.5	11.1	4.9	12.8	9.6	6.4	10.7	11.3	3.2	21.6	6.2	1.2	4.8	5.4	3.0	17.2	2.2	0.7	1.2	3.4	6.3	0.0	15.1	13.5	19.0	12.7	8.8	30.1	0.0	1.1	9.7	3.2	0.0	15.9	7.8	4.2	6.2	2.8	7.9	0.0	22.4	0.0	0.0	3.7	4.6	21.5	0.0	38.7	0.2	0.0	12.7	0.3	2.5	2.9	3.2	4.4	13.3	0.0	0.1	13.2	0.6	8.2	6.1	16.8	9.5	3.7	2.4	21.6	17.8	1.2	0.0	3.4	29.3	0.0	0.0	0.0	1.0	4.0	32.8	6.2	1.1	2.4	3.3	0.9	4.1	3.2	5.4	2.6	4.1	2.7	5.1	1.5	0.1	4.8	1.2	21.6	0.5	3.0	11.6	10.1	11.3	9.7	9.2	10.0	10.9	9.3	9.0	11.1
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 163.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 75.1;HaCaT: 71.6;Hep G2: 59.5;PC-3: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"CAB025915: , HPA051456: , HPA058518: AB_2683740"	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	28.6	12.3	8.2	15.2	9.1	4.4	33.2	5.6	13.8	36.3	33.3	15.4	38.5	36.4	25.9	11.6	78.0	25.1	19.0	33.5	8.7	8.4	22.3	23.4	57.4	17.9	10.0	7.9	12.3	5.8	4.0	25.7	22.1	14.3	56.4	13.1	34.9	10.5	163.1	23.0	16.5	40.6	16.9	8.1	15.3	48.6	7.8	4.0	2.4	78.8	36.2	21.0	80.0	26.4	0.4	0.7	3.9	0.7	0.3	0.5	0.5	10.5	35.1	0.4	7.1	4.6	2.1	27.4	45.0	1.8	8.3	0.9	18.5	16.0	0.0	75.1	12.0	71.6	5.8	2.5	1.3	0.8	3.7	5.8	30.4	59.5	6.3	0.1	0.3	8.6	10.2	0.0	0.6	5.0	12.9	0.3	15.9	13.8	1.5	0.2	25.2	74.9	0.1	29.3	0.5	1.6	29.4	13.7	12.8	37.4	13.4	0.3	8.2	1.0	26.8	22.3	43.5	7.1	30.2	0.8	0.8	0.6	26.0	5.6	3.0	0.0	0.6	0.9	0.1	0.2	0.0	0.1	0.1	0.0	0.7	0.4	0.0	0.5	3.9	0.3	0.7	0.0	0.0	0.5	8.2	9.1	5.6	13.8	8.7	8.4	10.0	7.9	14.3	4.0
ID3	"bHLHb25, HEIR-1"	ENSG00000117318	"Inhibitor of DNA binding 3, HLH protein"	Q02535	1	23557918-23559794	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 117.9"	"Cell line enhanced"	"Detected in many"		"U-698: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 47.4;naive B-cell: 42.9"	"Group enriched"	"Detected in many"	37	"B-cells: 47.4;T-cells: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021353, HPA024677"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB021353: , HPA024677: AB_2671647"	"unprognostic (6.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.19e-2)"	"prognostic favourable (1.27e-5)"	"unprognostic (5.58e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.37e-3)"	"unprognostic (8.36e-2)"	33.5	12.2	13.3	18.9	15.5	6.0	41.6	2.4	14.4	22.0	25.9	16.6	31.4	18.9	21.7	17.8	20.6	33.8	22.9	42.2	21.1	12.4	21.3	11.1	25.8	15.3	16.6	9.1	27.2	10.2	4.2	31.1	31.3	17.7	38.9	13.0	42.6	9.1	117.9	17.0	14.2	17.0	13.3	16.9	12.4	21.6	6.9	20.7	20.5	82.8	19.3	10.7	35.0	72.1	47.4	0.9	0.5	0.2	0.0	24.9	6.1	3.2	20.0	6.9	24.0	3.1	0.4	8.0	24.1	2.1	13.5	1.7	1.2	0.1	21.4	24.9	9.0	27.6	8.5	3.2	1.3	0.1	8.8	0.3	26.1	10.7	9.7	0.0	0.0	10.1	16.9	0.3	0.2	12.0	0.1	0.2	12.2	7.9	2.8	0.0	6.0	5.0	26.7	12.7	0.7	0.1	7.6	10.1	7.9	23.0	17.1	1.7	4.4	0.5	24.7	19.1	10.2	9.5	12.5	6.7	6.0	82.5	4.2	0.2	11.1	0.0	0.2	0.0	0.6	0.2	0.2	47.4	10.9	2.1	0.7	42.9	18.2	7.2	0.5	0.0	0.2	0.9	24.9	6.1	13.3	15.5	2.4	14.4	21.1	12.4	16.6	9.1	17.7	20.7
IER3	"DIF-2, IEX-1, IEX-1L, PRG1"	ENSG00000137331	"Immediate early response 3"	P46695	6	30743199-30744554	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 142.2"	"Group enriched"	"Detected in some"	7	"A-431: 39.5;EFO-21: 14.9;HBEC3-KT: 49.2;RPTEC TERT1: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA043847	Approved									"HPA043847: AB_2678699"	"unprognostic (2.83e-3)"	"unprognostic (9.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavourable (5.57e-4)"	"prognostic unfavourable (6.36e-5)"	"unprognostic (1.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (3.10e-7)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.77e-2)"	30.1	24.1	1.9	43.2	1.5	3.0	6.1	0.8	2.7	21.5	9.0	4.7	77.8	2.7	7.3	12.5	47.2	10.0	16.7	22.8	2.1	1.3	17.9	15.9	20.1	6.0	3.1	0.5	11.2	17.7	2.7	3.8	10.3	5.1	9.9	2.7	6.4	10.8	142.2	5.8	14.2	4.2	7.2	5.4	12.1	18.6	5.5	1.7	3.9	4.5	37.1	27.8	33.9	22.5	0.4	0.0	1.6	0.4	0.0	0.4	0.0	39.5	0.0	0.0	4.6	1.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.9	2.5	0.0	0.0	49.2	0.0	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.6	6.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	1.5	0.8	1.8	2.1	1.3	3.1	0.5	5.1	1.7
ILDR1	"DFNB42, MGC50831"	ENSG00000145103	"Immunoglobulin like domain containing receptor 1"	Q86SU0	3	121987323-122022258	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.9;seminal vesicle: 27.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.5;HDLM-2: 9.6;MCF7: 5.9;RT4: 8.9;T-47d: 6.4;U-266/70: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018207	Approved				"Intracellular and membrane"					"HPA018207: AB_1851742"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.46e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.37e-1)"	"prognostic favourable (5.79e-9)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.21e-2)"	0.3	1.5	0.3	0.7	0.4	0.0	1.8	0.3	0.3	8.6	5.6	0.3	28.9	2.0	1.6	17.2	5.9	3.4	4.7	0.3	0.3	0.2	8.0	0.4	2.9	0.3	0.3	0.3	0.9	16.5	14.8	4.1	2.6	0.4	4.9	5.0	1.3	10.6	27.8	0.3	1.7	2.4	0.3	0.3	1.1	0.3	1.5	0.3	0.9	5.1	1.9	3.7	5.6	1.6	5.1	0.5	1.5	0.7	0.1	1.0	0.4	3.4	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	7.5	1.3	0.1	0.0	1.2	0.0	0.0	0.0	9.6	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.0	0.1	0.1	0.0	0.0	0.1	2.7	3.4	8.9	0.3	0.1	0.0	0.9	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.1	7.4	1.6	1.3	0.0	0.2	0.1	0.6	0.7	0.1	0.2	0.4	0.2	5.1	0.2	0.3	0.5	3.4	0.4	0.3	1.5	0.1	0.2	0.4	1.0	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3
IRX3	IRX-1	ENSG00000177508	"Iroquois homeobox 3"	P78415	16	54283304-54286763	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 87.8"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 28.5;NB-4: 47.2;RPTEC TERT1: 56.9;T-47d: 29.4;THP-1: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062522			Approved	Vesicles				Vesicles	Vesicles	"HPA062522: AB_2797268"	"unprognostic (4.21e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.25e-1)"	4.4	2.5	1.8	0.1	2.1	0.0	38.3	3.8	0.7	15.3	0.5	1.5	46.8	0.1	4.0	18.1	14.1	5.3	0.2	46.9	3.2	3.6	9.8	1.0	46.8	1.9	4.6	0.3	1.6	2.1	15.4	3.4	1.0	7.8	10.0	0.0	5.9	20.5	87.8	9.1	33.8	0.2	0.6	8.2	0.2	7.7	1.4	3.2	0.4	8.9	9.1	6.5	2.6	6.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.2	0.2	3.7	3.6	2.0	0.8	0.4	1.5	3.4	3.3	0.8	1.0	1.6	0.0	0.5	2.3	6.9	3.0	0.8	4.5	3.3	2.3	0.0	5.0	3.4	0.1	3.8	1.0	0.6	14.4	6.4	2.9	0.0	0.0	0.0	28.5	1.7	7.0	47.2	0.2	0.0	5.3	4.6	0.0	56.9	1.4	2.5	0.4	4.8	12.3	0.5	29.4	47.1	0.8	14.1	1.5	2.5	1.2	0.0	0.0	0.0	9.2	12.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.8	2.1	3.8	0.3	3.2	3.6	4.6	0.3	7.8	3.2
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383391-51394738	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 30.3"	"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 80.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5"	"Group enriched"	"Detected in some"	12	"basal ganglia: 8.5;hypothalamus: 8.6"	HPA057416	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	2.2	1.5	0.0	0.0	4.0	0.0	0.1	0.0	0.2	14.4	1.6	0.0	4.2	2.3	1.3	0.5	0.2	0.0	0.2	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.4	0.0	2.8	10.0	2.0	13.2	2.5	6.4	1.0	30.3	0.1	1.1	0.7	0.6	0.1	0.0	10.7	1.6	0.7	3.1	0.3	0.2	0.4	2.4	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.6	1.2	0.9	0.0	0.0	1.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.8	0.0	0.0	0.0	5.1	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.0	0.0	0.2	0.0	5.5	0.0	0.0	2.0	0.7
JPH4	"JPHL1, KIAA1831"	ENSG00000092051	"Junctophilin 4"	Q96JJ6	14	23568035-23578800	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.7;seminal vesicle: 37.8"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 9.9;SH-SY5Y: 24.6;U-2 OS: 18.6"	"Cancer enhanced"	"Detected in some"		"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.4;myeloid DC: 5.9"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.9;monocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013492			Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB013492: "	"unprognostic (3.30e-2)"	"unprognostic (1.91e-3)"	"unprognostic (5.05e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-3)"	"unprognostic (5.98e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.96e-3)"	1.9	12.3	33.6	2.0	43.8	1.3	1.6	45.3	63.7	3.4	1.9	2.1	8.0	1.8	17.1	6.2	1.5	5.1	1.6	1.3	32.3	16.8	2.7	1.3	3.4	2.0	8.3	27.6	6.2	1.5	3.1	23.2	1.6	9.8	11.6	1.7	0.8	1.2	37.8	1.2	1.6	2.2	13.9	4.2	2.9	1.7	2.2	10.9	0.0	1.3	0.0	1.7	1.7	1.8	0.0	5.9	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.5	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	9.9	24.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	33.6	43.8	45.3	42.6	32.3	16.8	8.3	27.6	9.8	10.9
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849110	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 22.3;RPMI-8226: 15.0;U-266/70: 8.9;U-937: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553"	Enhanced									"CAB018656: AB_2131551, HPA048553: AB_2680438"	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favourable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	3.0	78.2	1.0	5.1	1.0	3.4	3.1	0.6	1.2	5.0	13.7	4.1	88.1	14.2	1.9	15.9	1.5	2.1	12.2	10.7	1.5	1.0	13.8	1.0	11.4	5.8	1.2	0.8	1.6	25.6	5.6	2.7	1.8	1.8	7.5	4.6	2.5	9.5	83.6	0.8	1.0	18.4	1.5	1.4	5.5	31.2	3.6	1.5	1.6	36.2	0.9	4.8	5.5	3.6	1.2	5.6	5.3	4.7	0.0	1.7	1.4	0.0	0.1	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.6	1.0	3.7	0.0	0.1	0.5	0.0	0.0	0.2	1.0	0.0	2.6	0.3	0.2	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.8	0.2	0.1	0.0	15.0	5.6	1.8	0.5	4.1	0.5	0.0	0.0	0.1	5.7	0.0	0.0	0.2	0.1	0.0	8.9	0.0	0.0	0.0	8.8	0.0	1.6	4.7	4.7	0.0	2.6	0.1	1.2	0.6	0.1	5.6	0.6	1.7	1.7	5.3	0.0	3.7	1.9	0.5	1.4	1.0	1.0	0.6	1.2	1.5	1.0	1.2	0.8	1.8	1.5
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.1;Hep G2: 16.5;RPTEC TERT1: 26.8;U-2 OS: 12.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	Nucleoplasm	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.96e-5)"	"prognostic favourable (8.01e-4)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favourable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.0	0.3	0.3	0.8	0.4	2.1	1.1	0.9	2.0	5.0	7.8	5.1	0.0	5.6	0.6	0.6	0.3	15.1	5.3	0.2	7.7	0.0	1.8	16.5	3.0	0.1	0.0	2.4	0.4	8.2	6.5	0.5	0.1	0.0	0.8	0.1	0.2	0.4	3.8	0.3	0.2	0.0	0.0	26.8	2.0	1.3	0.1	0.0	0.1	2.5	0.8	0.6	0.4	0.1	12.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8
KIAA1549		ENSG00000122778	KIAA1549	Q9HCM3	7	138831381-138981318	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 27.5;seminal vesicle: 39.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 20.0;SH-SY5Y: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019560	Uncertain		Approved	"Nuclear membrane,Intermediate filaments"				"Nuclear membrane"	"Nuclear membrane"	"HPA019560: AB_1852418"	"unprognostic (7.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.30e-2)"	"prognostic favourable (3.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.28e-2)"	2.1	3.2	3.3	0.6	4.4	0.6	2.9	1.2	8.3	2.7	1.8	1.6	27.5	1.5	3.7	4.1	1.4	4.9	2.5	1.9	3.1	2.0	8.0	1.5	4.7	0.3	1.6	3.8	2.6	12.9	6.5	3.6	4.6	3.7	3.1	1.5	2.0	4.4	39.0	1.4	2.6	1.8	2.9	3.3	1.2	3.0	2.9	1.2	3.1	2.2	0.1	0.4	3.8	4.4	0.3	0.1	1.5	0.1	0.3	0.2	0.0	5.0	9.5	8.4	14.8	0.1	0.0	4.9	5.1	4.6	3.0	3.8	8.9	3.1	0.0	3.2	7.8	1.0	5.3	1.5	3.6	2.4	3.2	2.4	10.3	2.2	1.3	3.6	3.4	1.2	2.3	1.1	1.6	4.9	1.9	0.1	3.3	4.7	2.6	3.5	8.0	20.0	7.1	4.3	0.0	1.5	3.1	11.2	19.2	2.7	5.1	2.2	4.2	2.2	3.1	3.0	3.1	0.0	4.8	0.7	0.0	0.2	4.0	1.4	7.1	1.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.5	0.3	0.1	0.1	0.0	0.0	3.3	4.4	1.2	8.3	3.1	2.0	1.6	3.8	3.7	1.2
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672671-32773062	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 14.6;seminal vesicle: 19.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;Hep G2: 16.4;REH: 4.4;RPTEC TERT1: 9.1;SCLC-21H: 3.5;U-698: 4.8"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	97	"memory B-cell: 10.7;naive B-cell: 8.5"	"Lineage enriched"	"Detected in single"	108	"B-cells: 10.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"hippocampal formation: 22.7;olfactory region: 20.4"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"				Cytosol	Cytosol	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.6	0.1	0.4	1.0	0.4	1.5	0.6	0.4	1.0	2.4	0.4	0.4	14.6	0.0	1.5	1.4	0.4	6.3	0.4	0.4	0.4	0.3	4.3	0.4	0.4	5.1	0.4	0.4	1.1	0.4	10.3	1.1	0.4	1.5	1.6	0.0	1.0	0.4	19.3	0.4	0.1	2.3	0.4	0.4	9.5	0.1	2.8	0.4	0.4	11.7	0.4	3.8	0.4	0.7	10.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	16.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	4.4	1.4	0.0	9.1	0.0	3.5	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	1.0	0.4	0.3	0.4	0.4	1.5	0.4
LCNL1	FLJ45224	ENSG00000214402	"Lipocalin like 1"	Q6ZST4	9	136981904-136986410	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.1;seminal vesicle: 3.7;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;fHDF/TERT166: 1.4;HSkMC: 1.0;TIME: 1.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"																				"unprognostic (1.39e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.08e-3)"	"unprognostic (5.14e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.03e-5)"	"unprognostic (6.46e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.34e-9)"	"unprognostic (4.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.93e-1)"	0.1	0.0	2.2	0.0	1.8	0.0	0.1	0.4	1.9	1.0	0.1			0.0	0.3	1.6	0.0	0.4	0.2	0.5	2.0	1.3	0.3	0.0	0.2	0.7	3.1		0.0	0.0	0.0	0.0	0.5		1.0	0.0		0.0	3.7	1.0	0.0	0.2	0.1	2.6	0.3	0.1	2.5			0.0		0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0										
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 277.8;salivary gland: 181.9;seminal vesicle: 177.1"	"Group enriched"	"Detected in some"	10	"RPMI-8226: 29.1;TIME: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	27	"neutrophil: 4.0;non-classical monocyte: 13.5"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 13.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted in other tissues"	600000000	600000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	1.0	0.3	0.4	8.8	0.5	277.8	23.0	0.3	0.3	53.1	0.3	3.2	108.0	0.0	0.7	39.3	3.8	0.9	2.2	2.5	0.6	0.6	20.8	0.6	10.8	1.3	0.6	0.0	0.3	2.7	0.0	1.2	0.8	1.5	13.0	0.0	0.2	181.9	177.1	0.4	1.2	0.9	0.1	0.7	9.1	22.6	2.8	0.1	4.0	1.6	13.4	30.7	2.3	1.0	0.0	0.3	4.0	13.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.5	29.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	0.8	0.1	0.4	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	13.5	0.3	0.0	14.7	0.4	0.5	0.3	0.3	0.6	0.6	0.6	0.0	1.5	0.1
LY6G6D	"C6orf23, G6D, Ly6-D, MEGT1, NG25"	ENSG00000244355	"Lymphocyte antigen 6 family member G6D"	O95868	6	31715356-31717804	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.4;skin 1: 21.4"	"Cell line enriched"	"Detected in some"	4	"HEL: 6.1"	"Cancer enriched"	"Detected in some"	22	"colorectal cancer: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"					HPA054412	Uncertain				"Intracellular and membrane"					"HPA054412: AB_2682480"			"unprognostic (5.48e-2)"		"unprognostic (1.25e-1)"					"unprognostic (2.81e-2)"		"unprognostic (2.13e-1)"						0.6	0.2	0.1	0.0	0.7	0.2	0.1	0.0	0.6	5.1	2.7	0.3	1.7	0.1	0.5	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	5.6	0.6	0.3	0.3	7.4	0.1	21.4	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.7	0.0	0.6	0.5	0.0	0.1	0.0	0.4	0.0
MARCOL		ENSG00000248109	"MARCO like"		5	148221650-148243580	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.8;epididymis: 5.7;seminal vesicle: 3.1;skeletal muscle: 2.9"	"Cell line enriched"	"Detected in some"	8	"HeLa: 124.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.3	0.0	3.8	0.0	0.7	5.7	0.0	0.0	0.0	0.9	0.0		1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.1	2.9	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0										
MCF2	"ARHGEF21, DBL"	ENSG00000101977	"MCF.2 cell line derived transforming sequence"	P10911	X	139581770-139708227	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.7;brain: 23.1;seminal vesicle: 18.8;testis: 18.2"	"Cell line enriched"	"Detected in some"	11	"U-251 MG: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.11e-4)"	"unprognostic (8.95e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.62e-4)"	"unprognostic (4.02e-2)"	0.7	30.7	5.2	0.8	8.1	1.0	0.5	3.3	12.4	0.5	0.5	0.9	12.5	0.5	0.5	13.4	0.5	1.2	1.1	1.4	7.1	11.3	2.0	0.6	0.5	1.0	8.9	5.7	11.5	0.7	0.5	3.3	0.5	23.1	1.8	0.5	2.8	1.3	18.8	0.6	0.6	0.5	0.5	6.3	1.3	0.6	18.2	2.4	0.0	1.6	0.0	0.6	0.6	0.1	0.1	0.3	0.6	0.1	1.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	2.4	0.0	0.4	0.4	1.9	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	28.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.6	1.0	0.0	0.3	0.0	0.0	5.2	8.1	3.3	12.4	7.1	11.3	8.9	5.7	23.1	2.4
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.5;THP-1: 58.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	Cytosol	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.4	6.6	3.1	0.6	0.0	2.0	3.9	4.5	5.4	0.2	1.1	13.0	1.2	1.0	5.2	4.3	7.5	3.5	1.6	2.1	1.5	0.0	0.0	10.5	2.3	7.7	3.5	4.7	18.5	7.6	1.1	0.0	3.3	2.0	0.2	3.5	3.5	3.5	1.6	2.5	6.5	3.0	0.7	6.1	1.6	2.4	1.5	11.1	1.1	0.5	58.2	0.7	1.0	1.9	3.3	8.5	0.6	1.1	2.9	10.4	8.8	3.2	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3
MTRNR2L5		ENSG00000249860	"MT-RNR2-like 5"	P0CJ72	10	55599303-55600041	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"														"Secreted - unknown location"															"unprognostic (2.11e-2)"				"unprognostic (1.20e-1)"				0.4	1.8	1.5	1.2	2.5	0.2	0.4	0.4	2.3	0.4	0.6	0.4	0.0	0.5	0.4	1.3	0.4	0.4	0.6	0.5	1.0	0.5	0.9	0.4	0.4	0.3	1.4	0.6	0.4	0.7	0.1	0.8	0.1	0.6	0.4	0.3	0.0	4.7	7.0	16.4	0.4	0.8	0.5	0.4	0.4	0.5	0.5	0.9	0.0	0.4	6.6	0.3	1.0	0.4	0.2	0.1	1.8	0.4	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.4	0.0	0.9	0.4	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.0	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	1.8	0.1	0.1	0.1	0.0	0.1	1.5	2.5	0.4	2.3	1.0	0.5	1.4	0.6	0.6	0.9
MUC6		ENSG00000184956	"Mucin 6, oligomeric mucus/gel-forming"	Q6W4X9	11	1012821-1036706	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 426.4;seminal vesicle: 478.2"	"Cell line enhanced"	"Detected in single"		"A549: 2.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 58.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	14	"basal ganglia: 20.1"	CAB002165	Enhanced				"Secreted to digestive system"					"CAB002165: AB_442114"	"unprognostic (1.90e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.23e-2)"	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.4	5.3	0.1	0.3	426.4	13.1	0.5	3.1	2.1	0.5	118.1	0.1	0.0	0.0	0.4	1.3	0.1	0.1	0.0	0.0	0.1	36.5	0.1	0.0	0.1	0.0	5.2	0.1	0.0	0.1	478.2	0.2	0.2	0.1	0.1	0.0	0.2	76.6	0.2	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.5	0.0	0.5	0.0	0.5	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810552	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.5;BJ hTERT+: 4.1;fHDF/TERT166: 4.8;WM-115: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	4.9	2.3	2.2	4.6	3.7	0.8	7.0	1.9	2.7	8.3	8.3	5.4	23.8	2.4	9.7	10.5	2.3	5.0	8.9	5.4	2.5	1.8	7.0	3.7	3.3	1.3	2.3	2.0	5.4	3.9	20.6	3.0	6.4	4.0	9.6	3.3	4.4	17.0	29.3	1.8	3.2	6.6	6.0	3.6	2.6	4.5	1.9	2.9	4.9	3.5	2.6	1.7	8.7	5.0	0.1	1.7	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.2	0.0	3.5	11.5	0.1	2.3	4.1	0.5	0.7	0.1	1.2	0.0	0.4	4.8	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	3.2	0.6	0.1	0.0	0.4	0.0	0.1	2.3	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	1.7	0.2	0.0	0.0	0.2	0.2	0.8	3.1	0.1	0.5	2.2	0.1	0.1	0.5	0.0	0.0	0.0	1.5	0.0	4.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	1.7	0.0	0.0	2.2	3.7	1.9	2.7	2.5	1.8	2.3	2.0	4.0	2.9
NEURL3	"Lincr, LOC93082, RNF132"	ENSG00000163121	"Neuralized E3 ubiquitin protein ligase 3"	Q96EH8	2	96497643-96508109	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 26.3;salivary gland: 22.4;seminal vesicle: 10.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;CAPAN-2: 16.6;RPMI-8226: 10.5;RT4: 5.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"														"unprognostic (4.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.57e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.9	0.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0		5.3	0.6	1.8	0.0	0.0	0.1	0.0	26.3	0.0	0.0	0.0	0.2	1.4	0.1	0.0	22.4	10.8	0.4	0.0	1.2	0.0	0.2	0.0	0.1	0.2	0.0	6.4	0.0	0.5	0.1	0.4	0.0	0.3	0.2	0.7	0.1	0.1	0.1	3.0	1.0	0.5	0.0	0.3	0.0	0.0	4.1	0.0	0.4	0.3	0.2	2.4	16.6	0.0	1.3	0.0	2.5	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	2.2	5.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.1	3.0										
NLGN4Y	KIAA0951	ENSG00000165246	"Neuroligin 4, Y-linked"	Q8NFZ3	Y	14522573-14845650	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.8;seminal vesicle: 15.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 19.6;fHDF/TERT166: 15.0;HDLM-2: 17.5;hTCEpi: 13.1;U-138 MG: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.0;memory CD4 T-cell: 1.7"	"Group enriched"	"Detected in many"	12	"B-cells: 3.0;T-cells: 1.7"									HPA001651	Approved				"Intracellular and membrane"					"HPA001651: AB_1079470"			"unprognostic (2.31e-1)"		"unprognostic (9.19e-2)"	"unprognostic (2.84e-5)"	"unprognostic (7.85e-2)"	"unprognostic (6.46e-2)"	"unprognostic (8.80e-3)"		"unprognostic (7.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.89e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.88e-1)"		"unprognostic (5.65e-2)"	1.4	1.9	4.7	1.4	18.7	0.4	1.3	11.2	23.8	0.4	2.5	11.2	2.4	1.2	0.4	4.0	4.3	0.4	4.8	0.8	4.9	5.7	2.0	4.4	1.3	2.7	3.7	0.0	0.5	3.3	0.4	2.9	0.9	12.6	12.6	3.1	7.2	2.2	15.3	0.6	1.3	2.0	3.7	3.5	1.1	1.5	1.3	0.0	2.5	2.6	4.0	2.5	6.0	0.0	3.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.3	19.6	1.2	1.6	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	3.1	17.5	0.0	0.0	0.0	2.9	2.1	0.0	0.0	6.8	13.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.2	0.0	4.0	0.0	0.0	1.3	0.0	4.7	7.5	2.6	0.0	0.0	0.0	0.0	0.0	0.4	5.6	14.4	0.0	0.0	3.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.0	1.7	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	4.7	18.7	11.2	23.8	4.9	5.7	3.7	0.0	12.6	0.0
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874345	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0"	"Cell line enriched"	"Detected in some"	21	"CACO-2: 25.9"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 1.8"												"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favourable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.1	0.1	0.2	8.8	0.2	0.0	0.1	0.2	0.2	0.2	28.3	0.0	15.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	36.3	0.0	0.1	18.0	0.1	0.8	1.7	0.7	0.1	0.1	0.1	0.4	0.0	0.4	0.1	0.0	0.1	0.6	0.1	0.2	0.7	0.9	0.6	0.8	1.5	0.2	0.4	0.9	0.4	0.3	0.2	0.0	0.3	0.3	0.0	0.0	0.0	25.9	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.4	0.6	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	1.1	1.0	0.7	0.9	0.6	0.6	0.4	0.0	0.9	0.4	0.5	0.6	0.3	0.6	0.2	0.8	0.2	0.3	0.2	0.5	0.6	0.3	0.6	0.3	0.7	1.1	0.2	0.9	0.3	0.3	0.5	0.3	0.3	0.2	1.1	0.2	0.1	0.1	1.5	0.6	0.1	0.8	0.6	0.7	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0
NPFFR2	"GPR74, NPFF2, NPGPR"	ENSG00000056291	"Neuropeptide FF receptor 2"	Q9Y5X5	4	72031804-72148067	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;seminal vesicle: 10.1"	"Group enriched"	"Detected in some"	10	"NTERA-2: 8.8;RPTEC TERT1: 11.4;SH-SY5Y: 13.5;U-2 OS: 13.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"olfactory region: 5.3"	"Low region specificity"	"Detected in many"			HPA026825			Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA026825: "	"unprognostic (1.28e-1)"		"unprognostic (1.05e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.40e-5)"	"unprognostic (5.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-1)"	0.9	0.2	5.5	0.7	2.6	0.2	1.4	0.2	3.5	0.5	0.5	0.0	0.0	0.5	0.1	2.8	0.3	0.8	0.4	0.4	0.9	2.9	0.6	0.2	0.2	0.6	0.5	4.0	0.3	1.2	0.1	1.0	4.6	1.5	3.2	0.9	1.4	0.3	10.1	0.3	0.7	0.5	0.2	0.6	0.5	0.4	1.6	0.0	15.4	1.2	0.0	0.6	2.5	0.7	0.6	0.3	2.3	0.3	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	11.4	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.2	1.1	0.8	0.3	0.3	0.2	0.1	5.5	2.6	0.2	3.5	0.9	2.9	0.5	4.0	1.5	0.0
NR4A2	"HZF-3, NOT, NURR1, RNR1, TINUR"	ENSG00000153234	"Nuclear receptor subfamily 4 group A member 2"	P43354	2	156324432-156342348	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 102.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 14.2;HMC-1: 10.5;U-266/70: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000543, CAB010481"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"CAB010481: AB_2298676, HPA000543: AB_1854631"	"unprognostic (4.26e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.11e-1)"	15.0	58.5	3.1	10.2	5.7	49.1	7.5	15.2	14.4	9.1	4.2	7.3	11.0	1.4	6.4	7.5	5.7	13.6	21.3	15.8	5.2	2.6	5.9	7.6	12.5	2.8	4.8	4.2	60.0	4.2	8.7	23.7	2.3	5.1	11.7	8.5	5.3	18.0	102.1	6.1	5.3	6.0	8.4	5.9	2.1	8.3	3.8	3.7	2.1	6.8	8.0	5.3	17.8	7.5	0.7	2.8	10.1	2.3	0.0	1.6	0.6	0.8	1.2	0.5	1.7	3.1	0.6	0.8	1.0	5.2	0.4	1.3	0.0	3.6	0.0	1.2	0.4	1.5	2.5	0.7	0.4	1.2	1.3	0.9	14.2	0.0	0.6	0.8	10.5	0.6	1.1	0.4	0.4	0.3	1.4	1.0	1.0	1.7	0.0	0.8	2.2	0.9	0.2	0.7	3.0	0.6	0.8	2.6	0.1	2.5	3.9	6.9	0.2	0.9	0.7	2.8	0.8	0.7	0.4	14.2	1.5	0.0	5.2	0.9	6.6	3.0	2.3	3.4	1.6	0.5	0.9	0.7	0.5	0.8	2.8	0.5	0.9	0.4	10.1	0.0	0.9	0.0	0.5	0.6	3.1	5.7	15.2	14.4	5.2	2.6	4.8	4.2	5.1	3.7
NR4A3	"CHN, CSMF, MINOR, NOR1"	ENSG00000119508	"Nuclear receptor subfamily 4 group A member 3"	Q92570	9	99821855-99866891	"Cancer-related genes, Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 80.6"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 21.0;HeLa: 7.3;SK-MEL-30: 14.5;U-266/70: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;NK-cell: 1.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.3;NK-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043360	Uncertain									"HPA043360: AB_10961186"	"prognostic favourable (5.97e-4)"	"unprognostic (6.92e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.69e-1)"	19.9	46.5	3.5	10.2	4.5	22.1	5.9	1.6	5.0	9.7	4.8	9.5	6.3	0.8	10.7	6.1	3.1	15.7	16.6	37.3	4.1	2.5	3.8	7.1	12.4	1.2	1.6	3.1	37.2	4.0	4.0	12.2	4.7	5.0	12.0	3.2	7.0	1.6	80.6	28.5	1.5	4.2	23.0	5.1	2.6	9.0	1.3	3.4	7.6	4.2	15.5	1.9	23.5	7.5	0.0	0.2	1.3	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.1	1.2	0.4	1.0	1.3	21.0	0.2	0.2	0.2	0.1	0.1	0.3	0.5	0.1	0.4	0.0	0.1	1.8	0.3	0.1	7.3	0.0	0.1	0.1	2.0	0.3	0.0	0.5	0.1	0.0	0.0	0.5	0.1	0.6	0.0	0.2	0.0	0.6	0.0	0.9	0.0	0.0	0.1	0.4	0.4	2.3	1.7	14.5	0.0	0.0	0.1	1.4	0.4	1.7	0.1	8.6	0.1	0.0	0.9	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	3.5	4.5	1.6	5.0	4.1	2.5	1.6	3.1	5.0	3.4
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2"	"Cell line enhanced"	"Detected in some"		"AF22: 6.1;HAP1: 11.4;HEK 293: 8.4;NTERA-2: 20.9;SH-SY5Y: 4.6;U-2 OS: 10.5"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"											"HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	1.0	2.3	9.3	1.4	10.7	1.8	1.4	6.0	13.1	4.4	2.0	0.9	28.8	1.1	5.5	18.3	1.7	3.4	2.0	0.9	4.9	13.6	3.1	1.9	0.7	0.9	5.3	8.0	19.2	0.6	0.5	4.5	0.5	6.2	17.9	1.3	0.8	1.0	36.3	0.5	1.0	1.2	4.9	1.9	3.1	1.1	27.2	1.2	0.0	0.8	0.0	0.9	2.8	2.9	0.8	0.1	0.0	0.7	2.1	1.0	0.3	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.8	1.0	0.0	0.1	0.3	0.0	0.6	0.0	2.1	0.5	0.0	0.0	0.3	9.3	10.7	6.0	11.7	4.9	13.6	5.3	8.0	6.2	1.2
P2RX2	"DFNA41, P2X2"	ENSG00000187848	"Purinergic receptor P2X 2"	Q9UBL9	12	132618776-132622386	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 23.1;prostate: 11.1;seminal vesicle: 16.1"	"Group enriched"	"Detected in some"	4	"MCF7: 6.6;T-47d: 15.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"amygdala: 6.1;hippocampal formation: 8.6"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.12e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.79e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-1)"		"unprognostic (9.12e-2)"	0.4	0.1	6.1	0.5	0.6	0.0	0.3	0.3	1.6	0.7	1.5	0.3	3.0	1.1	0.3	23.1	5.3	2.5	0.3	0.3	8.6	0.9	1.1	0.3	3.6	1.8	0.3	0.3	0.3	0.3	0.0	0.9	0.7	0.3	11.1	0.3	0.6	0.3	16.1	0.3	0.0	3.4	0.3	0.3	2.4	1.3	1.3	0.3	0.3	0.3	0.3	0.8	0.7	1.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.6	0.1	0.4	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.1	0.0	0.0	2.6	0.0	15.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.2	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.1	0.6	0.3	1.6	8.6	0.9	0.3	0.3	0.3	0.3
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149315-133208606	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.0;placenta: 31.1;seminal vesicle: 23.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 15.8;MOLT-4: 13.2;TIME: 31.4;U-138 MG: 8.5;U-251 MG: 7.2"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	1.9	7.6	17.9	1.5	35.5	1.2	1.3	1.7	48.0	3.3	1.5	23.2	4.5	1.3	3.1	1.9	1.6	2.6	1.9	1.8	17.5	12.6	3.7	1.3	2.0	1.2	13.2	16.3	4.1	1.4	1.2	1.7	31.1	13.6	14.7	1.5	1.3	1.8	23.6	1.2	1.3	1.7	2.0	6.8	1.2	1.3	2.9	19.2	0.9	1.5	0.0	1.2	3.6	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	5.1	0.0	0.1	0.0	0.0	4.9	2.7	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.2	0.0	2.4	0.0	13.2	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	31.4	8.5	0.0	0.0	7.2	0.0	0.0	0.0	0.5	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.9	35.5	1.7	27.7	17.5	12.6	13.2	16.3	13.6	19.2
PCDH11Y	"PCDH22, PCDHY"	ENSG00000099715	"Protocadherin 11 Y-linked"	Q9BZA8	Y	5000226-5742224	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 21.9;seminal vesicle: 9.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;RPMI-8226: 2.4;U-266/70: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"																										"unprognostic (9.26e-2)"							"unprognostic (1.84e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.55e-2)"			0.2	0.3	4.5	5.4	3.1	0.3	0.1	0.0	21.9	0.2	0.4	1.1	2.7	0.2	0.2	0.3	0.5	0.1	0.3	0.5	4.2	5.6	0.2	0.2	0.3	0.4	1.8	0.0	0.5	0.2	0.2	0.2	1.8	0.7	0.5	0.9	0.9	0.3	9.1	0.2	0.4	0.6	0.2	0.4	0.6	0.4	0.4	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.5	0.4	2.0	0.3	0.8	0.3	0.6	0.0	0.2	0.4	0.4	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.2	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.2	0.1	0.7	1.4	0.2	0.2	0.0	2.4	0.3	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.8	0.3	0.1	0.2	0.0	0.1	2.3	0.0	0.2	0.3	0.2	0.1	0.8	0.3	0.2	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.3	2.0	0.8	0.1	0.4	0.1	0.6	4.5	3.1	0.0	21.9	4.2	5.6	1.8	0.0	0.7	0.0
PCP4	PEP-19	ENSG00000183036	"Purkinje cell protein 4"	P48539	21	39867317-39929397	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 177.9;seminal vesicle: 234.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 56.4;SK-BR-3: 9.5;T-47d: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"basal ganglia: 177.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005792	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA005792: AB_1855086"	"unprognostic (6.82e-2)"	"prognostic favourable (9.76e-4)"	"unprognostic (5.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.85e-7)"	"unprognostic (9.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	2.1	11.0	5.6	1.4	177.9	1.0	2.6	15.8	15.8	39.3	10.6	11.4	50.8	1.9	11.4	65.7	38.4	2.9	1.7	1.7	8.3	14.0	9.7	1.0	1.1	1.0	11.6	3.7	1.2	2.1	3.4	1.0	1.3	20.0	60.9	6.9	49.0	1.7	234.5	1.0	1.4	1.5	93.5	3.7	1.5	1.1	1.2	37.5	0.0	39.2	0.0	1.2	65.6	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.5	0.0	0.0	0.0	56.4	0.0	0.0	0.1	0.1	0.0	9.5	0.0	17.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	177.9	15.8	15.8	8.3	14.0	11.6	3.7	20.0	37.5
PDZRN4	"DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4"	ENSG00000165966	"PDZ domain containing ring finger 4"	Q6ZMN7	12	41188448-41574590	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 18.3;seminal vesicle: 20.8"	"Cell line enriched"	"Detected in some"	9	"U-266/70: 8.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042101	Enhanced									"HPA042101: AB_2732496"	"unprognostic (6.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.41e-3)"	1.6	1.3	2.4	5.0	1.8	0.1	2.6	2.7	3.7	3.1	13.9	1.0	13.8	1.3	1.1	18.3	4.1	3.4	3.0	0.5	2.1	2.1	0.8	0.9	0.5	0.1	1.8	2.4	3.3	0.8	0.3	0.7	4.5	2.5	8.3	4.0	4.8	0.6	20.8	0.6	0.8	4.2	17.2	5.0	0.4	5.9	4.1	2.0	0.0	0.5	0.5	0.5	7.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.8	2.7	3.3	2.1	2.1	1.8	2.4	2.5	2.0
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18247614-18648416	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0"	"Group enriched"	"Detected in some"	5	"BEWO: 2.9;HaCaT: 4.6;hTERT-HME1: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.3	0.6	0.2	0.1	0.2	0.0	6.7	0.2	0.3	0.6	0.3	0.1	54.2	0.0	0.3	30.7	4.2	0.6	6.0	0.2	0.3	0.2	9.6	8.8	0.3	0.1	0.3	0.1	0.3	1.2	8.1	0.4	1.2	0.1	2.4	0.0	0.1	13.1	46.0	0.2	7.0	2.2	0.2	0.3	0.2	15.1	2.1	0.1	0.1	0.5	1.6	0.5	0.9	0.9	0.1	0.1	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	8.5	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.1
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell line enhanced"	"Detected in many"		"A549: 16.7;HeLa: 24.3;RPMI-8226: 30.2;U-2197: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Cytosol		78000	78000	Cytosol	Cytosol	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: "	"prognostic favourable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	16.7	0.0	0.0	10.5	4.2	0.0	0.6	6.4	0.8	1.4	0.1	6.6	0.0	0.0	0.0	1.2	10.4	3.1	0.3	5.1	0.2	3.1	24.3	0.0	6.5	4.5	1.6	2.3	2.2	8.4	1.7	7.0	6.8	2.5	0.0	0.0	0.0	0.0	0.9	2.2	0.0	0.0	30.2	0.0	2.3	0.1	0.0	2.5	0.8	2.9	0.3	6.2	1.4	6.2	0.8	28.5	1.3	1.0	0.0	0.0	2.3	13.6	8.8	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell line enriched"	"Detected in some"	8	"AN3-CA: 26.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	26.5	0.0	0.0	2.8	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.1	0.0	0.1	2.1	0.2	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;prostate: 30.9;seminal vesicle: 34.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 17.9;NB-4: 20.1;SCLC-21H: 43.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 31.4"	"Group enriched"	"Detected in many"	4	"amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7"	HPA057253			Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	3.6	3.5	17.6	6.3	10.1	4.4	3.3	3.6	31.0	9.3	8.2	10.9	1.8	2.1	8.2	3.0	2.8	3.7	2.7	1.9	30.9	6.0	1.4	0.9	2.0	6.1	12.3	18.1	5.5	1.1	0.8	4.5	5.6	7.5	30.9	2.6	4.3	1.5	34.0	3.0	2.1	4.4	8.6	15.2	2.5	4.4	1.9	9.0	0.0	1.1	0.0	3.5	9.0	8.2	2.2	0.5	2.1	0.0	0.7	2.4	0.4	0.9	0.0	0.3	0.0	0.9	3.2	0.0	2.4	8.8	1.2	1.4	0.0	0.9	0.0	0.0	3.0	0.3	0.0	1.0	5.3	3.7	0.8	0.3	0.0	0.0	1.8	3.7	1.1	2.0	0.0	4.8	1.4	0.1	0.0	1.6	17.9	0.0	1.7	20.1	0.0	7.3	0.6	0.0	0.0	0.5	0.1	43.4	6.0	0.1	0.0	0.0	0.0	1.9	3.7	3.1	0.4	2.3	0.1	0.7	0.0	0.0	7.8	1.7	0.4	0.0	0.0	0.0	1.6	0.0	2.4	0.3	2.1	2.0	0.3	2.2	1.3	0.7	2.1	0.7	0.0	0.5	0.9	0.4	17.6	10.1	3.6	31.0	30.9	6.0	12.3	18.1	7.5	9.0
PRLR		ENSG00000113494	"Prolactin receptor"	P16471	5	35048756-35230589	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.3;placenta: 45.7;seminal vesicle: 42.7"	"Cell line enriched"	"Detected in some"	18	"T-47d: 91.5"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 20.6"	"Region enriched"	"Detected in many"	7	"pons and medulla: 54.3"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 2.8"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.8"					"Low region specificity"	"Detected in some"								"Intracellular and membrane"						"unprognostic (3.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.84e-4)"	"unprognostic (2.50e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.84e-5)"	"unprognostic (1.24e-1)"	0.5	13.3	1.8	0.2	5.6	0.3	13.3	0.4	1.4	23.5	5.3	10.7	36.6	3.5	25.1	10.0	1.1	2.1	2.0	0.6	7.6	2.4	17.8	5.9	0.6	0.0	0.6	0.2	3.2	4.3	11.5	15.7	45.7	54.3	3.2	3.0	0.5	1.8	42.7	0.4	2.6	10.1	6.4	0.7	0.4	3.3	2.0	0.4	0.1	0.5	0.5	0.0	1.4	6.2	0.0	0.2	0.1	2.8	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.7	0.1	0.4	0.3	0.8	0.2	0.1	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.0	91.5	0.7	0.0	0.5	0.5	0.1	0.3	0.0	0.0	0.0	0.9	0.0	0.2	0.1	2.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.8	5.6	0.4	1.4	7.6	2.4	0.6	0.2	54.3	0.4
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.1;testis: 109.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067599, CAB070417"	Enhanced		Uncertain	Vesicles				Vesicles	Vesicles	"CAB070417: AB_11152035, HPA067599: AB_2685869"	"unprognostic (7.50e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	5.4	20.8	4.0	10.2	8.7	6.1	6.1	3.7	11.5	18.7	13.3	5.7	44.4	4.1	17.0	21.7	9.6	9.6	13.2	3.3	4.0	3.5	10.8	9.0	5.4	10.7	2.7	7.7	75.3	19.9	20.1	2.4	3.2	2.9	14.9	10.2	4.4	11.1	138.1	1.5	10.3	6.3	12.2	3.9	7.6	14.3	109.7	3.1	26.2	7.8	5.5	10.9	15.1	10.2	21.9	17.7	10.5	12.5	15.0	22.7	16.7	31.0	20.6	7.2	13.0	8.9	10.5	4.0	15.5	8.5	17.2	16.7	14.6	25.0	9.1	7.0	7.4	23.6	13.8	16.9	20.3	24.5	29.8	11.2	17.0	13.5	8.2	22.1	11.5	10.1	11.4	12.7	17.0	7.0	8.3	12.7	14.5	21.4	33.7	10.2	15.3	27.8	18.0	30.8	23.3	10.3	25.8	13.9	9.4	18.7	0.7	11.7	18.6	10.0	6.5	13.5	9.8	49.5	16.5	30.0	11.0	21.7	14.2	11.2	21.2	10.5	12.5	5.6	11.7	12.4	13.6	18.0	17.0	11.1	17.7	21.9	22.7	15.3	5.5	15.0	7.7	12.6	14.0	16.7	4.0	8.7	3.7	11.5	4.0	3.5	2.7	7.7	2.9	3.1
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540868-35554001	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.0;seminal vesicle: 25.2"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.0;SK-BR-3: 9.2;U-2 OS: 5.3;U-87 MG: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 527.8"	"Region enriched"	"Detected in all"	8	"basal ganglia: 265.8"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.6	7.9	8.6	2.5	71.0	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5.0	0.8	0.5	1.5	0.6	3.4	8.0	0.8	1.0	0.9	1.0	0.4	2.1	9.6	4.4	3.5	4.0	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0.0	1.4	0.1	1.4	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	3.5	0.0	0.6	0.0	0.0	0.1	0.9	0.3	1.4	1.1	0.2	0.7	0.0	0.2	3.0	0.2	0.2	0.0	1.3	0.0	0.9	0.0	0.2	0.0	1.7	0.0	0.1	0.2	4.0	2.7	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.4	1.5	0.0	1.1	0.0	0.0	2.4	0.4	2.6	9.2	0.0	0.7	0.3	0.1	2.2	5.3	0.2	1.0	2.3	0.7	0.0	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.6	71.0	1.8	23.5	4.1	5.0	3.4	8.0	2.1	15.3
RASL12	RIS	ENSG00000103710	"RAS like family 12"	Q9NYN1	15	65053337-65076690	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 51.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.4;CACO-2: 12.2;EFO-21: 19.8;NTERA-2: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (7.20e-5)"	"unprognostic (1.76e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (2.17e-4)"	13.6	3.0	9.4	3.5	11.9	0.4	6.2	4.2	8.2	22.1	13.0	17.7	8.6	2.7	26.7	18.7	19.4	21.9	12.7	22.4	12.0	13.3	2.2	0.8	15.2	3.1	19.2	7.1	13.0	2.0	1.3	3.2	11.0	27.2	27.5	4.8	13.0	4.9	51.5	21.3	4.6	3.4	24.6	19.0	4.4	3.2	13.2	14.0	0.0	3.4	3.3	1.6	18.6	14.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.5	4.4	0.1	0.0	0.4	0.0	0.0	12.2	0.0	0.0	19.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.4	11.9	4.2	5.4	12.0	13.3	19.2	7.1	27.2	14.0
RBFOX3	"FOX-3, HRNBP3, NeuN"	ENSG00000167281	"RNA binding fox-1 homolog 3"	A6NFN3	17	79089345-79516148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.4;seminal vesicle: 21.5"	"Group enriched"	"Detected in some"	6	"A549: 12.9;NTERA-2: 11.7;SCLC-21H: 18.7;U-2 OS: 8.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 60.4"	"Cell type enhanced"	"Detected in single"		"gdTCR: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030790, CAB078782"	Enhanced	Supported	Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB078782: , HPA030790: AB_10602305"	"unprognostic (2.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-15)"	"unprognostic (8.92e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-1)"	0.5	1.0	10.2	0.6	23.5	0.6	0.2	60.4	33.2	0.5	15.2	0.3	0.2	1.5	9.3	3.0	8.3	1.0	0.3	0.3	8.6	3.3	0.4	0.2	0.3	0.4	1.8	3.5	0.3	0.5	0.2	0.9	0.3	5.5	13.2	2.2	0.2	0.2	21.5	0.3	0.3	1.3	8.1	2.3	0.4	0.5	7.2	5.6	0.2	0.3	0.2	0.2	15.2	1.0	0.7	0.2	0.0	0.7	0.0	1.4	0.2	0.0	12.9	0.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	11.7	0.2	0.2	0.5	0.0	0.0	0.0	18.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.8	0.5	0.0	0.7	0.0	0.3	0.4	0.3	0.0	0.0	0.7	0.0	1.4	0.3	0.0	0.7	0.1	0.4	0.2	0.7	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.2	10.2	23.5	60.4	19.5	8.6	3.3	1.8	3.5	5.5	5.6
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593120	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 100.4;ductus deferens: 126.6;liver: 112.4;seminal vesicle: 106.7;testis: 146.5"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 74.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056919			Approved	Mitochondria	"Secreted to blood"	2300000000	2300000000	Mitochondria	Mitochondria	"HPA056919: AB_2797257"	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	1.1	100.4	0.4	1.8	1.8	0.0	7.7	0.2	0.5	4.0	1.0	1.6	126.6	0.6	4.8	5.0	0.5	3.6	34.3	5.6	0.6	0.4	33.6	112.4	0.3	1.9	3.1	0.3	6.4	33.8	0.0	0.8	0.2	1.9	1.9	0.0	0.9	10.9	106.7	6.6	0.7	0.7	0.4	1.5	36.1	2.0	146.5	0.6	0.1	0.9	1.5	0.6	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.1	5.1	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.2	0.5	0.6	0.4	3.1	0.3	1.9	0.6
SERTM2	LINC00890	ENSG00000260802	"Serine rich and transmembrane domain containing 2"		X	111511662-111522399	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in some"		"epididymis: 60.2;seminal vesicle: 38.7"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 19.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.0"																"unprognostic (9.56e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.65e-1)"		"unprognostic (3.79e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.93e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.77e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.57e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	15.2	0.5	0.0	9.1	0.0	14.2	60.2	0.0	0.0	0.0	0.0	0.0		0.0	1.7	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.6	1.7	0.5	4.6	0.0	0.1	0.0	38.7	0.0	0.0	0.0	2.2	0.0	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	1.0	0.0	3.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.8;BJ: 12.5;BJ hTERT+: 18.3;RPTEC TERT1: 14.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA024385: "	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favourable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	7.8	0.0	12.5	18.3	5.6	5.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	5.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340683	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 36.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"pons and medulla: 6.0"	"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved									"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favourable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.1	0.0	0.1	0.8	0.3	9.9	10.2	0.1	0.1	1.2	1.3	0.7	34.8	1.0	0.8	2.8	4.5	2.6	12.2	0.6	0.3	0.2	0.2	0.4	1.1	0.1	0.1	0.1	2.0	24.6	0.0	2.5	0.1	6.0	1.0	2.9	0.6	12.5	29.1	0.1	9.8	2.0	0.1	0.1	0.4	0.8	0.5	0.1	0.9	0.2	6.4	3.3	0.3	1.4	0.2	0.0	0.0	2.7	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.9	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	36.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.3	0.0	5.4	0.0	0.1	3.6	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.1	6.0	0.1
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8"	"Cell line enriched"	"Detected in single"	70	"HaCaT: 22.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"				"Plasma membrane"	"Plasma membrane"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	1.3	0.3	0.4	5.6	1.2	0.0	44.3	0.0	0.8	0.0	13.0	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.2	1.0	0.2	8.5	0.8	0.4	2.7	50.6	0.1	23.8	0.1	0.2	0.1	0.1	0.0	0.1	0.0	1.3	0.1	6.1	3.3	1.2	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	22.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.4	0.0	0.2	0.1	0.2	0.0
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932696-134052184	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 112.9;seminal vesicle: 147.1"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA013742	Enhanced									"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favourable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	9.3	14.7	1.0	6.0	1.0	0.0	6.2	0.4	1.6	13.9	8.1	1.5	112.9	3.7	18.4	4.5	7.8	11.5	15.3	10.1	0.7	0.5	32.9	4.2	56.8	10.6	0.7	1.2	7.2	9.2	16.1	6.5	40.3	1.8	13.7	7.2	15.1	8.2	147.1	1.5	4.5	10.1	13.6	3.0	17.7	8.3	3.0	0.6	4.6	33.6	8.6	9.0	10.5	7.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	2.0	0.2	0.0	0.0	0.0	0.0	44.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.0	10.3	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	1.0	0.4	1.6	0.7	0.5	0.7	1.2	1.8	0.6
SOD2		ENSG00000285441	"Superoxide dismutase 2"	P04179	6	159679119-159762529	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.2;bone marrow: 4.9;seminal vesicle: 3.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.0"									"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in single"																	140000000	140000000																					0.0	0.0	0.0	0.2	0.4	4.9	0.3	0.0	1.7	0.0	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0		0.3	1.0	0.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.6	0.5	0.2	1.0	0.1	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.4	0.9	0.4	0.2	0.8	0.2	0.0	0.3	0.4	0.4	1.4	1.3	0.5	0.1	2.0	0.8	1.4	0.5	0.2	0.1	0.4	0.4	0.3	1.0	1.8	0.5	0.2	0.0	0.2	0.4	0.7	0.6	0.1	0.1	1.0	1.4	1.6	0.0	0.1	0.2	0.6	0.4	0.0	0.7	0.1	0.1	0.0	0.5	0.3	0.4	0.4	0.0	0.7	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.6	0.6	0.2	0.2	0.2	0.1	0.6	0.4	0.4	0.7	0.2	0.1	3.2	0.6	0.4	0.4	0.9	0.8	0.4	0.9	0.2	0.4	0.2	0.5	0.2										
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Cell line enriched"	"Detected in some"	5	"BEWO: 44.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"				Nucleoplasm	Nucleoplasm	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.4	0.0	0.0	0.0	0.0	44.6	0.2	0.2	0.9	0.2	9.4	0.9	0.0	0.3	0.0	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	5.6	1.4	0.0	0.0	5.7	0.0	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.0;Hep G2: 8.1;U-2 OS: 23.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062611	Uncertain				"Secreted - unknown location"					"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (2.83e-6)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0
STAC2	24b2	ENSG00000141750	"SH3 and cysteine rich domain 2"	Q6ZMT1	17	39210536-39225872	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 94.0;seminal vesicle: 101.5"	"Group enriched"	"Detected in some"	5	"HeLa: 25.6;U-87 MG: 11.7"	"Group enriched"	"Detected in many"	7	"breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076925			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA076925: "	"unprognostic (1.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavourable (4.05e-5)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (1.12e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.17e-1)"	2.4	0.9	4.2	1.0	7.4	0.7	29.7	9.5	21.9	4.0	0.9	0.0	94.0	0.9	2.5	13.9	0.8	1.4	0.8	1.0	6.8	3.2	4.8	0.7	0.9	0.8	3.5	6.6	1.2	1.1	0.7	0.5	1.0	13.1	1.8	0.9	8.2	7.8	101.5	0.8	20.1	0.8	1.7	1.4	0.8	0.8	0.9	0.2	0.0	0.7	0.0	0.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	7.4	9.5	21.7	6.8	3.2	3.5	6.6	13.1	0.2
SULT1A2	"HAST4, STP2"	ENSG00000197165	"Sulfotransferase family 1A member 2"	P50226	16	28591943-28597109	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.5;liver: 26.2;seminal vesicle: 24.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.7;EFO-21: 8.6;Hep G2: 31.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"classical monocyte: 10.2;intermediate monocyte: 7.0;myeloid DC: 3.5;neutrophil: 12.6;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.5;granulocytes: 12.6;monocytes: 10.2"									"HPA049500, HPA051051"	Supported									"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (4.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.13e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.49e-4)"	"unprognostic (5.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.52e-3)"	1.0	1.9	0.6	2.5	1.0	0.5	1.2	1.6	0.7	0.3	9.8	0.6	5.9	25.7	0.5	1.1	0.9	0.6	1.6	2.1	0.8	0.5	2.3	26.2	11.9	0.3	0.6	0.6	0.9	1.4	1.0	1.2	2.7	0.7	0.3	6.8	4.6	0.9	24.2	0.2	0.2	37.5	0.2	0.6	2.7	0.7	0.3	0.2	0.5	4.5	0.5	0.2	1.9	1.1	0.2	3.5	12.6	10.2	0.4	0.5	3.9	1.3	0.6	0.6	0.5	0.1	0.3	6.7	0.7	0.0	0.1	0.0	1.3	2.9	0.2	8.6	0.2	1.1	0.3	0.4	0.2	0.4	0.3	1.2	1.6	31.9	0.5	1.0	1.3	0.2	0.5	0.5	0.1	0.2	0.7	1.4	0.1	1.5	0.2	2.0	1.0	0.3	1.2	0.2	0.6	0.1	1.3	0.4	0.9	0.2	4.5	0.0	3.1	0.6	0.4	1.6	1.0	1.3	0.5	2.4	1.3	0.3	0.4	0.5	0.5	1.1	10.2	0.1	0.3	7.0	0.5	0.1	0.2	0.2	3.5	0.2	0.3	0.3	12.6	0.4	3.6	0.8	0.4	3.9	0.6	1.0	1.6	0.7	0.8	0.5	0.6	0.6	0.7	0.2
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007617-101252866	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 76.0;skeletal muscle: 66.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.5;ASC TERT1: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 16.6;non-classical monocyte: 20.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB015211: , HPA037496: AB_2675507"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	14.4	4.0	3.0	5.5	4.2	7.3	14.1	10.1	5.1	7.6	19.6	2.2	52.8	4.3	7.8	12.2	8.4	13.2	12.0	24.1	4.8	2.7	8.9	12.8	11.8	6.8	3.0	3.8	5.1	27.5	3.9	8.5	4.4	6.1	25.7	3.8	6.7	15.1	76.0	66.3	15.2	22.7	7.7	5.0	11.3	13.3	11.3	2.8	3.3	5.3	8.3	8.0	8.7	8.6	0.6	4.0	0.2	20.6	0.0	0.3	1.8	2.0	12.8	1.0	3.7	36.5	26.0	10.5	1.2	22.3	0.9	1.1	4.5	3.3	0.9	11.5	0.9	6.4	2.1	9.8	0.6	0.6	1.9	0.6	4.2	15.5	2.5	0.0	11.0	12.0	9.4	1.2	9.3	13.0	0.2	1.1	1.1	5.6	1.1	6.4	2.8	13.7	2.5	3.2	0.2	7.4	13.6	8.0	3.9	1.7	3.1	4.4	0.9	9.4	10.7	0.5	1.9	1.9	0.8	2.1	0.1	0.0	4.7	3.2	3.3	0.0	5.1	0.2	0.1	16.6	0.2	0.2	0.1	0.1	2.8	0.6	0.3	0.2	0.2	0.0	20.6	4.0	0.1	1.8	3.0	4.2	10.1	5.1	4.8	2.7	3.0	3.8	6.1	2.8
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box 3"	O15119	12	114670254-114684164	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 117.7"	"Cell line enhanced"	"Detected in many"		"BJ: 33.8;BJ hTERT+: 32.2;RT4: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA005799: , HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favourable (3.28e-4)"	4.3	60.5	0.9	3.3	1.9	0.0	19.9	0.7	2.3	18.2	12.2	1.7	69.6	14.2	13.1	18.7	1.9	7.5	5.0	6.2	1.2	1.5	4.1	15.1	12.6	0.8	1.2	0.5	15.6	1.1	0.3	5.3	67.8	1.6	32.3	1.5	2.6	7.3	117.7	4.2	4.8	19.4	9.7	1.4	2.6	2.2	3.5	1.2	0.5	36.3	7.3	3.5	24.6	25.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	5.9	0.0	0.0	8.9	12.3	13.4	33.8	32.2	13.1	13.0	5.3	1.4	0.0	0.5	5.8	1.5	2.8	1.2	16.2	0.0	4.0	0.0	1.5	15.4	2.9	0.0	0.0	5.4	0.8	4.4	9.1	0.1	1.2	0.0	1.1	0.5	0.0	0.1	0.0	1.8	0.0	0.0	0.8	0.0	42.2	2.2	6.5	4.8	2.2	1.1	1.6	0.0	0.0	4.0	2.6	2.2	10.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.7	2.3	1.2	1.5	1.2	0.5	1.6	1.2
TMC4		ENSG00000167608	"Transmembrane channel like 4"		19	54160108-54173250	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 45.8;seminal vesicle: 49.1"	"Cell line enriched"	"Detected in some"	6	"T-47d: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.4;neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048635	Approved									"HPA048635: AB_2680470"	"unprognostic (7.55e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.68e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"prognostic favourable (1.54e-8)"	"unprognostic (6.70e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.79e-2)"	1.2	0.4	0.8	4.7	1.2	0.0	6.5	0.5	0.7	3.7	31.0	0.0	32.0	19.7	2.0	16.2	2.9	8.7	21.8	1.7	0.9	0.8	11.8	0.8	9.6	0.0	0.8	0.0	3.8	25.0	0.3	11.1	6.9	0.0	8.6	7.5	0.0	34.5	49.1	0.8	1.3	45.8	0.8	0.6	0.3	8.2	0.6	0.0	1.0	17.1	2.8	5.6	6.7	2.7	0.0	0.0	1.5	1.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.1	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.5	0.7	0.9	0.8	0.8	0.0	0.0	0.0
TMEFF2	"CT120.2, HPP1, TENB2, TPEF, TR"	ENSG00000144339	"Transmembrane protein with EGF like and two follistatin like domains 2"	Q9UIK5	2	191949043-192195709	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6;prostate: 46.3;seminal vesicle: 17.5"	"Group enriched"	"Detected in some"	4	"AF22: 16.9;LHCN-M2: 48.4"	"Cancer enriched"	"Detected in some"	21	"prostate cancer: 57.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015587	Approved				"Secreted in male reproductive system"					"HPA015587: AB_1858069"	"unprognostic (2.12e-3)"	"unprognostic (5.37e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.89e-7)"	"unprognostic (4.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.79e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-1)"	1.1	3.8	20.2	1.1	14.7	1.0	1.1	7.4	29.6	1.1	2.0	18.4	1.7	1.7	1.0	11.1	2.4	1.1	3.0	1.4	17.7	18.5	1.0	1.0	1.1	1.0	15.7	17.7	1.1	1.1	1.1	0.4	1.0	11.1	46.3	2.8	2.8	1.1	17.5	1.3	1.1	1.7	1.1	11.1	1.1	1.4	1.8	15.9	0.0	1.1	0.0	1.2	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	16.9	0.0	2.6	2.7	0.0	0.0	0.3	0.8	1.0	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.3	0.0	0.9	5.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.2	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	14.7	7.4	22.7	17.7	18.5	15.7	17.7	11.1	15.9
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 69.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"				Vesicles	Vesicles	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favourable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	15.0	8.6	9.2	6.1	10.9	11.1	9.2	2.6	6.8	3.9	17.0	6.0	36.3	14.5	4.5	4.1	10.5	5.5	8.8	14.7	6.6	5.9	8.4	1.7	35.8	7.6	4.6	3.5	11.9	17.2	11.1	8.7	6.6	7.0	6.2	14.8	18.7	7.6	69.7	32.0	15.2	33.1	4.6	2.9	6.9	9.9	2.2	5.1	4.5	11.4	6.0	5.8	5.0	5.1	0.4	1.4	25.9	1.7	1.1	0.9	0.8	4.7	10.9	9.0	5.8	11.1	8.2	5.5	2.4	5.6	5.1	3.3	8.5	7.5	3.8	16.3	3.7	7.0	7.7	12.6	5.0	10.5	5.3	25.9	5.9	3.5	6.6	11.4	37.1	11.3	22.3	9.1	12.7	9.9	8.0	4.6	9.0	9.5	11.9	14.5	8.0	7.9	5.5	6.9	3.2	8.1	5.0	8.4	9.4	15.3	15.1	7.0	4.4	11.4	22.0	4.3	3.2	5.0	3.4	2.7	3.4	3.1	11.3	14.3	11.5	25.9	1.7	7.2	0.3	1.5	0.9	0.1	0.4	0.3	1.4	0.4	0.2	0.3	8.8	1.1	0.9	0.2	0.5	0.8	9.2	10.9	2.6	6.8	6.6	5.9	4.6	3.5	7.0	5.1
TMEM238L	LINC00675	ENSG00000263429	"Transmembrane protein 238 like"		17	10794913-10804099	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"ductus deferens: 19.9;intestine: 19.0;seminal vesicle: 14.6;stomach 1: 23.0"	"Cell line enriched"	"Detected in some"	8	"RT4: 9.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (7.23e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.30e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.19e-2)"	0.0	0.0	0.2	7.5	0.6	0.0	0.6	0.0	1.0	0.0	18.3	0.0	19.9	8.8	0.0	1.1	3.2	0.0	9.5	0.0	0.4		0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	19.0	0.0	0.0	14.6	0.0	0.2	14.0	1.2	0.0	0.0	23.0	0.0	0.0	0.0	0.0	2.8	3.1	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	9.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TMEM35A	"FLJ14084, TMEM35"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078720-101096364	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;seminal vesicle: 46.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HUVEC TERT2: 31.7;SH-SY5Y: 8.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced		Supported	"Vesicles,Focal adhesion sites,Cytosol"				Vesicles	Vesicles	"HPA048583: AB_2680451"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.6	6.7	12.8	1.7	28.2	0.7	1.3	21.2	28.6	3.3	17.3	2.5	6.8	3.5	7.4	3.9	10.4	4.3	3.6	1.1	14.4	33.8	1.1	0.7	2.6	0.8	12.2	10.0	7.7	0.9	6.1	1.5	0.8	30.0	20.5	9.1	2.9	1.0	46.4	1.3	0.9	4.1	11.8	3.9	1.3	3.4	1.8	2.3	0.0	1.3	0.0	0.9	13.3	2.7	0.2	0.0	0.2	0.1	0.6	0.8	0.4	0.0	0.0	3.3	0.0	2.4	6.3	0.0	0.6	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	1.1	0.0	31.7	0.0	0.0	4.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	1.4	8.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.4	0.2	0.6	0.1	0.0	0.8	0.4	12.8	28.2	21.2	28.6	14.4	33.8	12.2	10.0	30.0	2.3
TNMD	"BRICD4, ChM1L, myodulin, TEM, tendin"	ENSG00000000005	Tenomodulin	Q9H2S6	X	100584802-100599885	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.4;seminal vesicle: 25.0"	"Group enriched"	"Detected in some"	13	"HAP1: 7.2;NTERA-2: 17.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA034961, HPA055634"	Uncertain									"HPA034961: AB_10670285, HPA055634: AB_2682868"	"unprognostic (3.60e-2)"		"unprognostic (9.84e-3)"	"unprognostic (3.19e-2)"	"unprognostic (7.77e-3)"		"unprognostic (2.42e-1)"			"unprognostic (2.15e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.40e-2)"	"unprognostic (9.60e-4)"	"unprognostic (6.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.48e-1)"	18.4	0.1	0.1	0.4	0.0	0.0	10.9	0.0	0.1	0.4	0.6	0.0	11.1	0.0	0.2	8.9	0.4	0.2	0.3	0.7	0.9	0.1	0.7	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	1.9	0.6	1.1	0.4	4.7	1.3	25.0	5.9	2.9	0.5	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	2.6	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.1	0.6	0.0	0.6	0.0
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.2;RPMI-8226: 1.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043315	Uncertain									"HPA043315: AB_2678422"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			6.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.5	0.0		0.2	0.5		0.0	4.0	0.0	0.0	6.3	0.0	0.0	0.0	0.5	0.9			3.1		0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0										
UNC5B	"p53RDL1, UNC5H2"	ENSG00000107731	"Unc-5 netrin receptor B"	Q8IZJ1	10	71212570-71302864	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 43.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.0;hTCEpi: 40.6;SH-SY5Y: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076687	Approved									"HPA076687: "	"unprognostic (3.98e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (3.01e-5)"	"unprognostic (8.82e-3)"	"unprognostic (6.79e-3)"	"prognostic unfavourable (3.80e-5)"	"unprognostic (7.70e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (4.17e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.25e-1)"	3.8	12.4	9.1	4.6	19.8	0.5	2.3	23.1	12.5	5.7	8.3	29.5	33.6	3.2	5.4	7.5	14.2	9.1	10.5	13.8	12.2	6.8	6.6	2.1	9.3	3.9	27.1	9.7	4.5	5.2	1.5	5.3	6.0	15.0	10.1	6.0	7.1	4.5	43.7	3.0	5.9	4.5	5.5	17.5	8.5	9.9	6.0	20.4	2.2	4.6	5.2	3.6	9.6	8.9	0.0	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.2	1.1	3.6	5.9	0.1	2.0	5.8	0.0	0.1	1.1	5.4	0.0	2.0	12.4	14.0	0.4	0.8	0.0	0.0	1.3	3.1	0.2	0.0	46.0	0.0	0.3	5.1	40.6	0.5	2.6	0.8	0.1	0.0	0.0	0.4	0.0	0.0	3.1	0.1	0.0	1.4	0.0	0.0	6.1	6.2	38.1	0.4	0.4	0.3	0.6	0.1	2.4	0.4	1.8	0.7	0.8	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	9.1	19.8	23.1	12.5	12.2	6.8	27.1	9.7	15.0	20.4
VWA1	"FLJ22215, VWA-1, WARP"	ENSG00000179403	"Von Willebrand factor A domain containing 1"	Q6PCB0	1	1434861-1442882	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 125.2"	"Cell line enhanced"	"Detected in many"		"A-431: 15.6;CACO-2: 15.8;CAPAN-2: 46.9;Hep G2: 28.0;SCLC-21H: 16.7;T-47d: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	190000	190000				"unprognostic (2.78e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.52e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (6.71e-2)"	13.9	6.4	13.1	17.5	16.2	1.3	9.4	2.7	19.6	12.4	26.3	46.1	34.8	9.4	18.1	13.9	15.7	13.2	15.6	8.9	17.5	9.5	14.0	71.3	13.6	9.0	22.4	12.1	13.9	23.2	5.0	5.1	23.9	15.7	47.0	4.2	11.4	23.9	125.2	6.0	8.6	8.9	34.7	29.8	4.7	17.8	11.8	21.5	0.4	16.6	3.9	4.9	30.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	5.2	0.7	5.4	0.1	0.5	8.5	1.0	0.0	0.8	0.0	15.8	46.9	0.0	15.0	0.4	4.1	5.5	2.7	0.1	1.0	3.8	0.5	0.0	28.0	1.2	0.0	1.9	0.9	0.1	0.3	0.0	0.2	0.5	0.0	0.0	3.9	0.0	0.3	2.1	1.4	0.2	0.2	0.7	0.9	2.7	16.7	2.6	0.0	14.5	1.9	21.2	0.2	0.5	0.0	0.2	0.1	5.1	0.1	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	16.2	2.7	19.6	17.5	9.5	22.4	12.1	15.7	21.5
WNT9B	"WNT14B, WNT15"	ENSG00000158955	"Wnt family member 9B"	O14905	17	46833201-46886730	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 31.6;epididymis: 13.0;seminal vesicle: 19.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	7	"thalamus: 6.4"	"Low region specificity"	"Detected in all"			"HPA058361, HPA059572"	Approved				"Secreted to extracellular matrix"					"HPA058361: AB_2683691, HPA059572: AB_2684067"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.48e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.52e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.37e-1)"	1.0	0.4	0.3	0.2	0.4	0.3	0.8	1.4	1.6	0.4	0.5	0.1	31.6	1.5	0.8	13.0	0.2	0.6	0.2	2.1	1.1	1.0	7.4	2.4	2.4	0.5	1.0	0.0	0.3	0.3	4.2	0.1	0.5	2.0	0.5	0.2	6.7	0.2	19.1	0.6	2.5	4.5	0.4	0.7	1.8	0.2	0.9	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.6	0.5	2.0	0.5	0.3	0.4	0.0	0.1	0.5	3.1	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.4	0.7	0.2	0.4	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.3	0.2	0.3	0.1	0.2	0.5	0.1	0.0	0.4	0.0	0.7	0.2	0.6	0.0	1.0	0.1	0.1	0.0	2.0	0.3	0.3	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.4	0.4	1.8	0.3	0.5	0.5	0.2	0.0	0.3	0.4	1.4	1.6	1.1	1.0	1.0	0.0	2.0	0.0
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129471-108250537	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8"	"Cell line enriched"	"Detected in some"	21	"RT4: 26.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Region enhanced"	"Detected in all"		"cerebellum: 44.0"	"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	1.4	1.2	6.5	0.5	12.5	0.4	1.0	44.0	15.2	5.4	1.7	1.6	0.0	0.7	6.9	3.0	3.8	2.0	0.5	0.5	10.0	3.0	1.3	0.4	0.8	0.5	1.3	6.0	0.6	2.1	0.4	0.9	0.6	1.9	6.0	0.7	9.9	0.5	18.2	0.5	0.6	0.9	9.2	1.5	0.5	2.0	0.6	2.0	0.0	21.8	0.2	0.5	3.0	0.9	0.8	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.9	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	6.5	12.5	44.0	15.2	10.0	3.0	1.3	6.0	1.9	2.0
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 13.2;testis: 17.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 7.7;hTCEpi: 7.0;K-562: 12.3;U-266/84: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				Nucleoli	Nucleoli	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.8	1.8	2.6	0.4	7.2	0.4	2.3	9.5	4.7	2.3	1.1	0.3	9.3	0.7	1.6	7.5	1.0	3.1	0.7	1.2	2.4	2.3	2.3	3.2	1.9	0.5	1.3	2.9	4.1	3.4	3.2	6.9	3.0	3.5	3.4	1.5	0.8	2.4	13.2	0.5	0.7	0.8	1.1	0.8	0.6	1.0	17.6	0.7	0.0	4.1	0.0	0.6	1.4	1.2	0.5	0.7	1.1	0.7	0.4	1.4	0.2	1.8	1.8	1.8	0.0	0.0	0.0	2.2	0.4	0.0	0.4	1.1	0.0	1.2	0.0	7.7	0.1	1.0	0.0	2.1	0.4	0.0	5.1	0.4	1.2	1.8	1.2	0.0	0.0	1.1	7.0	0.1	3.5	0.0	12.3	0.0	0.1	1.3	0.0	0.1	1.8	0.9	0.6	0.8	0.1	2.0	2.1	2.0	4.8	0.0	1.9	0.0	0.0	0.6	0.0	0.0	2.2	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.3	0.4	0.1	0.2	0.4	0.4	0.2	0.5	1.4	1.0	1.1	0.4	0.7	0.7	0.1	0.2	2.6	7.2	9.5	4.7	2.4	2.3	1.3	2.9	3.5	0.7
ZFHX4	"FLJ20980, ZFH4"	ENSG00000091656	"Zinc finger homeobox 4"	Q86UP3	8	76681219-76867285	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 12.9;TIME: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023837	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA023837: AB_1859013"	"unprognostic (2.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.63e-3)"	"unprognostic (6.14e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.15e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.20e-7)"	"unprognostic (3.50e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.50e-4)"	"unprognostic (5.89e-4)"	4.9	8.8	6.2	2.1	10.7	0.8	5.8	1.4	8.5	6.3	5.1	7.7	14.1	1.0	2.2	8.9	1.7	2.0	2.9	1.5	7.2	4.3	1.6	7.3	1.1	1.5	8.3	4.3	5.5	1.5	1.2	13.7	1.1	5.9	3.2	2.0	8.0	1.6	29.1	6.5	1.4	1.3	11.8	11.6	1.2	2.0	15.6	9.8	0.0	1.2	2.4	1.0	7.8	5.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	2.4	0.0	4.8	6.3	0.0	2.0	2.9	2.4	2.5	0.0	0.0	0.0	3.9	3.4	0.2	4.8	0.6	4.4	0.0	7.1	0.1	0.0	0.0	1.3	0.0	0.3	12.9	0.2	6.2	2.5	0.4	0.0	0.2	4.7	0.0	0.0	0.0	0.4	4.1	0.0	4.3	0.0	3.8	0.0	0.0	4.5	0.0	0.5	0.0	0.6	0.0	28.1	2.4	3.7	7.1	4.7	7.2	0.7	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	10.7	1.4	8.5	7.2	4.3	8.3	4.3	5.9	9.8
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.3;seminal vesicle: 36.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.7;HBF TERT88: 6.5;NTERA-2: 16.5;U-2197: 6.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"											HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	1.5	1.0	1.1	3.6	2.5	1.6	1.8	6.9	1.1	3.0	1.7	1.2	20.3	0.5	3.3	2.7	2.1	2.8	1.0	1.4	0.8	0.6	1.7	0.7	2.4	3.0	2.1	0.3	4.7	3.4	12.7	1.4	3.8	1.7	4.1	2.1	3.2	1.2	36.4	1.2	2.8	2.3	3.3	1.6	2.3	2.7	1.6	2.2	4.1	10.3	0.7	2.9	4.9	2.9	0.5	0.4	1.8	0.2	0.3	0.9	0.2	0.0	0.0	3.9	9.7	0.0	0.0	0.0	1.0	0.4	3.8	4.5	3.3	2.3	1.4	1.8	0.7	1.0	0.0	0.6	6.5	0.0	0.9	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.3	0.0	0.0	0.1	2.0	5.5	16.5	0.0	0.0	3.5	0.2	2.0	3.4	0.0	3.5	0.0	1.2	0.2	1.9	0.0	0.0	1.0	0.0	6.9	3.8	0.0	1.5	0.0	0.0	0.0	1.5	0.8	0.2	0.3	0.1	0.0	0.9	0.2	0.2	0.4	0.4	0.5	0.3	0.1	1.8	0.3	0.0	0.2	0.7	0.2	1.1	2.5	6.9	1.1	0.8	0.6	2.1	0.3	1.7	2.2
